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The Small Ubiquitin-like MOdifier (SUMO) protein regulates numerous nuclear 
events such as transcription, mitosis and meiosis and DNA repair. These processes 
are critical to the programmed nuclear events of conjugation in ciliates and provide 
the potential to investigate developmentally regulated SUMOylation. We predicted a 
developmental increase in SUMOylation during late conjugation based on the 
extensive genome remodeling in the developing macronucleus (anlagen) of 
Tetrahymena thermophila. Immunoblotting of cell lysates from vegetative and 
mating cells using anti-SUMO antibodies revealed distinct developmental 
differences and an increased signal correlated with formation of the anlagen. 
Immunofluorescence of mating Tetrahymena cells with the same antibody revealed 
an increase in staining of the parental macronucleus until the signal shifts to the 
anlagen at 7 hours post-mixing. This along with the finding that GFP-Uba2 fusion 
proteins localize to the anlagen is consistent with a major nuclear role for 
viii 
 
SUMOylation during conjugation. Germ-line knockout mutants of SUMO (SMT3) and 
UBA2 are vegetative lethal and conditional mutants dependent on a cadmium-
inducible metallothionein promoter exhibit reduced cell growth and increased 
sensitivity to DNA damaging agents upon cadmium withdrawal. Interestingly, 
mating of Uba2p conditional lines leads to a cadmium-dependent delay after meiosis 
but prior to macronuclear development predicting a SUMOylation-dependent event. 
Additionally, in an effort to provide further insight into the various processes 
affected by SUMO modification, we utilized a proteomics-based approach to 
generate an unbiased spectrum of SUMO protein substrates from vegetative 
Tetrahymena. We used a two-step affinity purification scheme to isolate SUMO 
substrates from a tagged Tetrahymena strain. Proteins from the purification were 
then identified by subsequent LC-MS.MS analysis using a QuadTOF mass 
spectrometer. We identified 110 candidate proteins that were identified by 2 or 
more peptides. The nature of the protein substrates that were identified is 
consistent with roles of SUMOylation in modulating diverse cellular processes 
including transcriptional regulation, protein folding and translation, metabolism 
and crosstalk with other post-translational modifications. These results support 
multiple roles of SUMOylation in regulating various cellular processes in eukaryotic 
cells. Taken together, our findings provide the foundation for additional studies of 
SUMOylation during conjugation in Tetrahymena.
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CHAPTER 1 – INTRODUCTION 
 
SUMO is a Member of the Ubiquitin-like Protein Family 
Protein function is often regulated though additional or removal of molecular 
adducts collectively termed post-translational modification (PTM). Because of the 
dynamic nature of such modifications, PTMs are capable of rapid modulating 
protein function by affecting stability, localization as well as interaction with other 
proteins thereby altering the cellular proteome. Ubiquitin-like (UBL) or ubiquitin-
related modifiers are post-translationally attached to substrate proteins via an 
enzymatic pathway reminiscent to that used in ubiquitin (Ub). SUMOylation is one 
such UBL modification which involves the reversible and covalent conjugation of 
members of the SUMO (Small Ubiquitin-like MOdifier) family of proteins to various 
target proteins. Even though SUMO belongs to the Ub-like family of modifiers, its 
functions are very diverse and different from Ub itself. 
 
SUMO Isoforms and Structure 
SUMOylation affects several critical processes in eukaryotic cells and is 
required for cell viability in most eukaryotic systems (reviewed in (1)). Simple 
eukaryotes such as yeast, fruit fly and nematodes express a single SUMO gene. 
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In yeast, the SUMO homolog is named Smt3 (Suppressor of Mif Two 3) and 
the same nomenclature will be used throughout this thesis when referring to the 
gene (SMT3) or its product (Smt3p) in Tetrahymena (Table 1). There are four 
isoforms of the SUMO protein in mammalian cells, with SUMO-2 and SUMO-3 (also 
abbreviated as SUMO-2/3) sharing 97% sequence identity with one another and 
only ~50% identity with SUMO-1 (reviewed in (2)). A fourth SUMO protein (SUMO-
4) has been described in humans, and is expressed primarily in kidney cells (3). 
SUMO-1 shares the highest sequence similarity with SUMO in yeast and most lower 
eukaryotes and is the primary isoform that is conjugated on to protein substrates 
under normal conditions. SUMO2/3-adducts appear when cells undergo 
physiological stress although there are examples of proteins such as topoisomerase 
II, which disentangles DNA strands during replication, and CENP-E, which is a 
component of centromeres in mammals, that are modified by SUMO-2/3 under 
normal conditions too (4, 5). While there have been reports on paralog-specific 
functions of SUMO-2/3, these proteins display functional redundancy and have 
considerable overlap in substrate specificities with SUMO-1 (6, 7).  
The structures of human (8) and yeast (9) SUMO variants have been resolved 
recently and tertiary structures of both Ub and SUMO are very similar and nearly 
superimposable even though SUMO proteins share very little (~18%) sequence 
similarity with Ub (Figure 1) (10). A distinguishing characteristic of SUMO is that it 
contains an elongated and flexible N-terminal neck region that has been linked to 
polySUMO chain formation (11, 12). Remarkably, yeast mutants that lack the 
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extended neck region including the lysine residues required for auto-SUMOylation 
are viable without deleterious phenotypes which would suggest that, unlike Ub, the 
formation of polymeric SUMO chains is not essential in S. cerevisiae (13). Another 
similarity between SUMO and Ub is that the mature forms of both proteins end with 
two glycine residues (diglycine motif) necessary for conjugation of these proteins to 
lysine residues on target proteins (reviewed in (14, 15)). 
 
Table 1. Nomenclature of SUMO Pathway Enzymes in Model Systems. 
Enzyme Humans/Mammals S. cerevisiae T. thermophila 
SUMO paralogs SUMO-1 Smt3p Smt3p 
 SUMO-2   
 SUMO-3   
 SUMO-4   
E1 Activating 
Enzyme 
SAE1/SAE2 Aos1p/Uba2p Aos1p/Uba2p 
E2 Conjugating 
Enzyme 
UBC9 Ubc9p Ubc9p 
E3 Ligases PIAS1 Siz1p Unidentified 
 PIAS3 Siz2p or Nfi1p Unidentified 
 PIASx   
 PIASy   
 Mms21 Mms2p or 
Zip3p 
 
 Pc2 Unidentified  
 RanBAP Unidentified  
SUMO Proteases SENP1 Ulp1p Unidentified 
 SENP2   
 SENP3   
 SENP5 Ulp2p or 
Smt4p 
Unidentified 
 SENP6   





SUMOylation in Human Disease 
In the past few years, there have been increasing reports linking 
SUMOylation to human disease pathogenesis. Most notably, dysregulation of the 
SUMO pathway has been implicated in tumorigenesis and cancer onset (reviewed in 
(16, 17)). This is not surprising as SUMOylation regulates important tumor 
suppressor proteins such as p53, MDM2 and pRB (16). The link between 
SUMOylation and cancer is further solidified by several studies where increased 
levels of SUMO E1 Activating enzyme (18, 19), E2 Conjugating enzyme (20), SUMO 
E3 ligases (21) and SUMO proteases (22, 23) have been shown to contribute to 
human cancers. Myc is an oncogenic transcription factor frequently dysregulated in 
human cancer. In human breast cancer, SAE2 (Uba2p in S. cerevisiae and T. 
thermophila) is required for Myc-dependent tumorigenesis and patients with high 
levels of SAE2 suffer from increased metastasis (19). Inhibition of SUMOylation in 
this case may provide therapeutic benefits for patients with Myc-driven cancers.  
Many proteins that play critical roles in neurodegenerative diseases have 
also been identified as targets of SUMO. This list includes, but is not limited to, 
huntingin (Huntington’s disease), ataxin-1 (spinocerebellar ataxia type 1), tau 
protein (Parkinson’s and Alzheimer’s disease) and SOD1 (amyotrophic lateral 
sclerosis) (reviewed in (24)). Diabetes, which is a very common human disease, has 
also been linked to SUMOylation (25, 26). In mouse, the transcription factor c-Maf is 
a target of SUMO. SUMOylation of c-Maf reduces its transactivational capacity by 
sequestering it in promyelocytic leukemia nuclear bodies (PML-NBs). This prevents 
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c-Maf from binding to interleukin IL-4 which otherwise confers resistance to 
diabetic state (26). A similar study in mouse showed that overexpression of SUMO-2 
negatively regulates the transcriptional factor NF-κB. The reduced activity of NF-κB 
confers protection against diabetes in transgenic mice overexpressing SUMO-2 as 
NF-κB is unable to activate genes involved in the development of Type-1 diabetes 
(reviewed in (27)). Another major human disease linked to SUMOylation is 
cardiomyopathy which most commonly causes heart failure. Overexpression of the 
SUMO protease, SENP5 has been shown to result in elevated apoptosis leading to 
cardiac dysfunction (28). The increase in cell apoptosis is also seen with 
overexpression of the SUMO conjugating enzyme, Ubc9p where such apoptotic 
events precede other detectable pathological changes suggesting its underlying role 
in cardiomyopathy (29). Understanding the role of SUMOylation in human disease 
is, therefore, of tremendous utility as it provides insights into functions of protein 
substrates and mechanistic pathways that, when perturbed, cause diseased states. 
 
The SUMO Conjugation Pathway Involves 3 Enzymes 
SUMO-Activating Enzyme 
Modification of proteins by SUMO occurs through a biochemical pathway that 
is similar to attachment of Ub to target proteins (30). The first step in the pathway 
utilizes an E1-activating enzyme which is a heterodimer comprised of two subunits 
– SAE1 and SAE2 known as Aos1 and Uba2 in yeast respectively (31, 32) (Table 1 
and Figure 1). It is interesting to note that Aos1 and Uba2 resemble the amino- and 
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carboxyl-termini of Ub E1 enzymes (6, 32–34). Activation of SUMO occurs through 
an ATP-dependent step in which the carboxyl group of the C-terminal glycine of 
SUMO forms a thioester bond with a cysteine residue in the active site of the Uba2 
component of the E1 enzyme. In most eukaryotic organisms, there is a single E1 
enzyme required for the activation of SUMO proteins (6). This is in stark contrast to 
the Ub system, where several E1 enzymes (8 in humans for example) are known to 
initiate Ub activation (35, 36). There is no overlap of function between SUMO E1 
enzymes (as well as E2 and E3 enzymes) with the Ub system and vice-versa. In 
mammals and vertebrates, the single SUMO E1 enzyme will activate all isozymes of 
SUMO (34, 37). Budding yeast strains that lack Aos1 or Uba2 exhibit a lethal 
phenotype which indicates that the SUMO E1 is an essential enzyme in this 
organism (32, 33). In fission yeast, S. pombe, Aos1 deletion mutants are able to 
conjugate SUMO on to protein substrates at very low levels (38). This would suggest 
that Uba2 is the essential component of the E1 enzyme as it contains the catalytic 
active site. A less likely explanation would be that Aos1 paralogs from other UBL 
modifications may substitute for Aos1. 
Uba2 is expressed in all stages of Drosophila life cycle with an increase during 
embryogenesis that would indicate a requirement for SUMOylation during this stage 
of the life cycle (39). In the ciliate Tetrahymena thermophila, UBA2 transcripts are 
expressed throughout the vegetative life cycle but are most abundant during the 
sexual life cycle with a peak during the later stages corresponding to the generation, 
development and maturation of new somatic nuclei (40). This expression pattern is 
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consistent with the observation that E1 enzymes are found predominantly in the 
cell nuclei of other eukaryotic model systems (6, 33, 39). 
 
SUMO-Conjugating Enzyme 
In the second step of the SUMO conjugation pathway, activated Smt3p is 
transferred from the E1-activating enzyme to a cysteine residue in the active site of 
the E2-conjugating enzyme. Unlike the Ub system which displays a greater diversity 
of E2 enzymes, only a single E2 SUMO-conjugating enzyme, known as Ubc9, has 
been identified as of yet (7) (Table 1 and Figure 1). A second distinguishing feature 
of Ubc9 from other Ub E2 enzymes is that it is able to directly recognize substrate 
proteins and catalyze the formation of isopeptide bond between SUMO and 





Figure 1. SUMOylation occurs through a 3-step enzymatic pathway. Conjugation of 
Smt3p to substrate proteins occurs through a 3-step cascade that shares numerous 
similarities to the ubiquitin pathway. Precursor Smt3p undergoes cleavage by SUMO 
proteases to produce mature Smt3p revealing a C-terminal diglycine motif. Mature 
Smt3p is then activated by the E1 Activating enzyme, which is a heterodimer of 
Uba2p and Aos1p, in an ATP-dependent manner (only Uba2p is shown here). The E2 
conjugating enzyme, Ubc9p, assisted by several adapter proteins known as SUMO E3 
ligases, will then conjugate Smt3p onto a Lys residue of the substrate protein. SUMO 
proteases are also responsible for removing Smt3p moiety from substrates 
generating free Smt3p in the process. 
 
SUMO-Ligating Enzymes 
In the final step of the SUMO pathway, the SUMO-E2 thioester intermediate 
serves as a donor in the conjugation of SUMO moiety onto a substrate protein. The 
terminal glycine in SUMO forms an isopeptide bond with the ϵ amino group of a 
lysine residue in the target protein. Three groups of proteins have been identified in 
recent years that accelerate the conjugation of SUMO onto substrate proteins. These 
proteins share very few recognizable features and are collectively known as SUMO 
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E3 ligases. Surprisingly, these SUMO E3 ligases bear no semblance to typical Ub E3 
ligases. The most famous SUMO E3 enzymes are the Siz/PIAS family of proteins that 
contain the SP-RING that is analogous to RING domains of Ub E3 ligases. Siz/PIAS 
proteins bind to the E2-SUMO thioester intermediate and protein substrates which 
brings them in close proximity and promotes Smt3p transfer (reviewed in (2, 41)).  
A second and distinct class of E3 enzymes is represented by RanBP2 that sits 
at the nuclear pore complex and aids in the SUMO-modification of its target 
RanGAP1. RanBP2 does not contain either RING or HECT domains that are found in 
Ub E3 ligases and its E3 ligase domain favors preferential modification of RanGAP 
with SUMO-1 over modification by SUMO-2 in mammalian systems (41). RanBP2 
does not recruit RanGAP1 to Ubc9 but rather alters the structure of the SUMO-1-
Ubc9 thioester intermediate such that it has increased capacity to transfer SUMO to 
its RanGAP1 substrate. 
The last group of SUMO ligases comprise the human polycomb group protein 
2 (Pc2) which is a member of a large multi-protein complex that regulates 
transcriptional repression by altering chromatin structure. The effect of Pc2 in the 
increased SUMOylation of its substrate CtBP2 is modest and direct interactions 
between Pc2 and the SUMO-Ubc9 thioester intermediate have not been noted 





Substrate Selection for SUMOylation 
Attachment of SUMO to target proteins occurs on lysine residues that are 
typically part of the SUMO-modification consensus motif, ψKXE (where ψ 
represents aliphatic amino acids such as leucine, isoleucine and valine, and X is any 
amino acid) (reviewed in (42)). There are a few examples where glutamate, E in the 
SUMO tetrapeptide motif can be substituted with an aspartate, D (reviewed in (2, 
43)). It is to be noted that SUMOylation does not always occur within this motif and 
many lysines on substrate proteins that do not conform to the consensus motif are 
SUMOylated. An example of this is PCNA which is SUMOylated on two lysine 
residues: one of which resides in the consensus SUMO tetrapeptide motif while the 
other lysine residue does not and is present in a different location.  
At the same time, presence of the SUMO consensus tetrapeptide does not 
guarantee attachment of Smt3p which would suggest that other factors such as 
subcellular localization and availability of target lysines may also contribute to 
modification by SUMO (42). Whilst the requirements for SUMOylation are quite 
simple, identification of proteins as SUMO substrates based on the presence of the 
ψKXE sequence is not sufficient. As a result, methods that evaluate SUMOylation of 
the global proteome are increasingly gaining favor (44–48). 
 
SUMO Processing and DeSUMOylation by SUMO Proteases 
SUMO proteins are synthesized in the cell as precursor proteins that need to 
be proteolytically cleaved to generate the mature C-terminus. SUMO proteases, 
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designated Sentrin/SUMO-specific proteases (SENPs) expose the terminal glycine 
residue that is linked to the target lysine on substrate proteins. The terminal glycine 
forms part of the diglycine motif – two glycine residues in tandem that are highly 
conserved in Ub and UBL family of proteins (15, 49, 50). The removal of conjugated 
SUMO from substrates is also catalyzed by the action of SUMO proteases making 
SUMOylation a cyclical and reversible process (reviewed in (14)). SUMO proteases 
remove SUMO from substrates in response to stimuli and in doing so generate a free 
pool of SUMO protein that can be conjugated to substrate proteins as needed. Two 
SUMO proteases have been described in yeast, Ulp1 and Ulp2 with the former 
essential for viability (reviewed in (14)). Deletions in Ulp2 in yeast result in cells 
that viable but grow abnormally and are hypersensitive to DNA-damaging drugs 
(51, 52). 
It is of interest to study the mechanisms by which Ulp1 or SENPs proteases 
deSUMOylate proteins that are SUMO-modified because of their function in quick 
termination of SUMO-modification in response to various stimuli. The fewer number 
of proteases identified in the SUMO system (as compared to the much more complex 
Ub system) would suggest that these few proteases are highly active enzymes 





Regulation of SUMOylation as a PTM 
Control of Global SUMOylation 
The primary method of regulating global SUMOylation in the cell is by 
regulating the expression or activity of the enzymes of the SUMOylation pathway. 
An overall increase in SUMOylation levels has been observed in response to ethanol 
stress, hydrogen peroxide and heat shock (47, 53). On the other hand, 
downregulation of the total SUMOylation is observed when the amount of reactive 
oxygen species is decreased (54). This type of control is exercised by formation of a 
disulfide bond between the active site cysteine residues of E1 and E2 enzymes 
rendering them defunct to participate in SUMOylation. In the Ub system, E1 
enzymes, in addition to their primary role in activating Ub, can also establish 
substrate specificity by matching up with cognate E2s. The E2 enzyme Ubc9 itself 
possesses not only the capacity to catalyze SUMO transfer to the substrate, but also 
the capacity to select the lysine residue for modification. Because the SUMOylation 
pathway relies on a single E1 and E2, the regulation of these enzymes allows the cell 
to regulate the entire SUMO proteome at any given time. Stability of the E1 and E2 
enzymes is another mechanism by which the cell can modulate the activities 
associated with the SUMO pathway. For example, chicken adenovirus GAM1 controls 
E1 turnover by binding to the SAE1 (Aos1p) component and recruiting Cullin-RING 
Ub ligases that target it for degradation by the proteasome (55, 56). Decrease in 
SAE1 levels causes a drop in SAE2 (Uba2p) levels concomitantly (56). GAM1 also 
reduces E2 enzyme Ubc9p levels to lower overall SUMOylation although the 
13 
 
mechanism of this inhibition is not fully understood (55). Pathogens like the 
bacterium Listeria monocytogenes infiltrate host defenses by impairing global 
SUMOylation by targeting Ubc9 as well as other SUMOylated proteins for 
proteasomal-mediated degradation (57).  
Other methods to regulate SUMO pathway enzymes include sequestering of 
SUMOylation enzymes in different locations inside the cell. In budding yeast, the 
SUMO E3 ligase Siz1 is responsible for SUMOylation of septins. Siz1 is contained in 
the nucleus during interphase and at the onset of mitosis, it is release to the 
cytoplasm where it accumulates at septin rings and participates in their 
SUMOylation (58). Alcohol-induced stress in the same organism results in a rapid 
accumulation of the Smt3p protease Ulp1 in the nucleolus which consequently 
results in a dramatic increase in the levels and SUMOylation state of protein 
substrates (59). It is generally thought that SUMO E3 ligases (in addition to the 
identification of substrates by Ubc9) regulate SUMOylation as a PTM by displaying 
substrate preferences and in some cases, SUMO isoform-specific conjugation of 
particular targets (60). 
 
Crosstalk with other PTMs 
PTM modification by SUMO, Ub, and acetyl groups use lysine residues for 
attachment and it has become apparent over the course of several years that these 
PTMs can form a combinatory molecular switch to synergize or antagonize with 
each other adding yet another layer to protein regulation (reviewed in (61, 62)). As 
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these PTMs utilize lysines for covalent attachment, it is plausible that they compete 
with each other to bring about a more complex mechanism of protein regulation. A 
distinct function of Smt3p is to protect target proteins from Ub-mediated 
degradation. This is best exemplified in IκBα, an inhibitor of NF-κB transcription 
factor, which is degraded by Ub marking in cells responding to inflammation. In 
unstimulated cells, IκBα is protected from Ub-mediated degradation through 
SUMOylation which uses up the lysines otherwise targeted by Ub (63). Another 
example is cAMP response element binding protein (CREB) that is degraded in 
mammalian cells suffering from hypoxic stress. Overexpression of SUMO-1 stabilizes 
CREB in hypoxia which suggests a similar mechanism of protection offered by 
SUMOylation against ubiquitylation (reviewed in (64)). 
There are cases, however, when Ub and SUMO act less antagonistically 
providing evidence for crosstalk between the two PTMs. Many substrates of SUMO 
contain a specific protein motif, denoted SUMO Interacting Motif (SIM) that is 
characterized by a sequence motif of hydrophobic amino acids V/I-X-V/I-V/I. These 
hydrophobic residues of the SIM domain contact a hydrophobic patch within SUMO 
(reviewed in (2)). RNF4, which belongs to a class of proteins referred as SUMO-
targeted Ub ligase (STUBl), houses four SIMs which recognize SUMO moieties on 
target proteins. Upon recognition of polySUMO chains on proteins, RNF4 will start 
ligating Ub on the SUMO-modified protein thereby marking the protein for 
degradation by the proteasome (65). 
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In addition to the SUMO consensus tetrapeptide motif, the highly conserved 
phosphorylation-dependent SUMOylation motif (PDSM), that comprises the SUMO 
consensus motif and an adjacent proline-directed phosphorylation site (ψKXEXXSp; 
where serine is phosphorylated), has been described (reviewed in (42)). Some 
examples of proteins that are regulated both by SUMOylation and phosphorylation 
(referred as phospho-SUMOyl switch) are heat-shock factors (HSF), and peroxisome 
proliferator-activated receptor γ (PPARγ) and myocyte enhancer factor 2 (MEF2) 
(reviewed in (66)). In these cases, phosphorylation of the serine residue of the 
PDSM enhances SUMOylation as the negative phosphate group interacts with a basic 
path on the E2 Ubc9 enzyme (reviewed in (2)). Apart from such a phospho-SUMOyl 
switch, phosphorylation of SUMO substrates is also shown to regulate the 
SUMOylation state of the proteins. In some cases, dephosphorylation event at a 
PDSM causes a loss of the SUMO from the same PDSM motif. This decreased 
SUMOylation is coupled with increased acetylation indicating yet another variant of 
the SUMO consensus tetrapeptide – an acetyl-SUMOyl switch based on 
communication between SUMOylation and acetylation (67, 68). Acetylation of the 
target lysine within the PDSM blocks SUMOylation, leading to transcriptional 
activation through inhibition from SUMO-mediated repression (reviewed in (42)). 
SUMO proteins can be modified by acetyl groups further contributing to the 
regulation of SUMOylation. In mammals, SUMO-1 is targeted for acetylation which 
results in neutralizing of basic charges in its SIM docking sites and consequently 
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lowers its binding affinity to SIM domains in substrates such as PML, Daxx and PIAS 
proteins (67). 
 
Biological Functions of SUMOylation 
SUMOylation and Inhibition of Gene Transcription 
Many SUMO-modified proteins reside in the nucleus but cytosolic targets 
have also been identified. The most prominent group of proteins that have been 
identified as SUMO substrates are transcription factors. These proteins are active in 
the nucleus where they regulate gene expression by modulating transcription. 
Mutations that prevent modification by SUMO in the transcription factors Elk-1 and 
Sp-3 result in an increase in transcription from respective promoters linking SUMO 
to repression of gene expression (69, 70). The role of SUMOylation in 
downregulating transcription is further reinforced by the observation that simply 
targeting SUMO or Ubc9 to promoters has been shown to reduce promoter activity 
(71). While not much is known about the general mechanism by which SUMOylation 
regulates transcription, it is becoming increasingly apparent that SUMO-
modification results in interactions between transcriptional factors and 
transcriptional co-repressors such as chromatin modifying proteins that induce a 
more heterochromatic state (reviewed in (42)). For example, the histone 
deacetylase HDAC6 is able to bind to its co-repressor p300 only when it is 
SUMOylated ((1)). Another such interaction is seen in the case of PIAS proteins 
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(SUMO ligases) and Sp3 where PIAS binds strongly to SUMO-modified Sp3 than 
unmodified Sp3 (reviewed in (1)). 
 
SUMOylation is Required for Maintenance of Genome Integrity 
SUMOylation was first linked to DNA repair with the finding that thymine 
DNA glycosylase (TDG), a base excision repair enzyme that removes thymine or 
uracil from T-G or U-G mismatched base pairs, is a substrate of SUMO. TDG removes 
harmful DNA lesions leaving an abasic site to which it binds tightly. TDG has to be 
SUMOylated for it to relax its hold on the DNA helix which allows repair to occur 
quickly by downstream enzymes and frees up the TDG to seek other base lesions 
(72–74). 
SUMO E3 ligases such as the PIAS proteins in mammals have been implicated 
in genome stability (75, 76). PIAS proteins are components of the DNA damage 
repair pathways and aid in the SUMOylation and subsequent recruitment of repair 
proteins to sites of double strand breaks (DSBs) (75). Although SUMOylation is 
important for response to DNA damage, it has also been demonstrated that 
deSUMOylation via the action of SUMO proteases also plays a role in genomic 
maintenance. The SUMO protease Ulp1 in yeast is an essential gene required for cell 
viability and Ulp2 mutant cells are viable but suffer from hypersensitivity to DNA 
damaging agents (51, 52). Taken together, these observations would suggest that 
SUMOylation and deSUMOylation may be coupled together in response to genotoxic 
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stress to regulate the assembly and disassembly of protein factors involved in the 
repair response. 
 
SUMOylation in Chromosome and Sub-nuclear Structure 
It is not surprising that a growing body of work links SUMOylation to the 
control of chromosome dynamics. In fact, all SUMO-pathway components (E1, E2, E3 
and SUMO proteases) have shown genetic associations with maintenance of 
chromosome structure and segregation events. In S. pombe, complete disruption of 
the Smt3p homolog, Pmt3, results in cells that are barely viable and suffer from 
defects in mitosis and chromosome segregation (77). In the budding yeast S. 
cerevisiae, mutants of the E1-activating enzyme Uba2 display hypersensitivity to 
microtubule destabilizing drugs and arrest early in mitosis with short and 
frequently misaligned spindles (78). Yeast Ubc9 mutants are unable to 
appropriately activate the anaphase promoting complex (APC) that helps in the 
progression through mitosis (79).  
SUMOylation has a well-defined role in dictating sub-nuclear architecture. 
This is best exemplified in the case of promyelocytic leukemia (PML) nuclear-bodies 
(PML NBs), where SUMOylation is necessary for maturation of the tumor 
suppressor protein PML which is the primary component of PML NBs (80, 81). PML 
NBs exemplify the function of the SUMO Interacting Motif (SIM) that are 
characterized by a tetrapeptide sequence motif of hydrophobic amino acids that 
make contact with a hydrophobic patch within the SUMO protein (reviewed in (2)). 
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SUMOylation of PML plays a critical role in its activity of recruiting partners, many 
of which are SUMOylated themselves. The ever increasing list of proteins of the PML 
complex also includes proteins that specifically recognize SUMOylated partners via 
their SIM domains. A combination of SUMO conjugation on target proteins and SIM 
domains on interacting partners is then essential for the formation of PML NBs (80, 
81). 
 
SUMO in Developmental Processes 
Studies in several model systems have demonstrated that SUMOylation is 
critical developmental programs. In mitosis, specific roles for SUMO in regulating 
the normal execution of the cell cycle have been described since SUMO was first 
discovered two decades ago. In S. cerevisiae mutations in Uba2p or Ubc9p cause cells 
to arrest at the G2/M boundary indicating that SUMOylation is necessary for 
progression through the cell cycle (32, 79). Severe chromosome segregation defects 
are observed in mice lacking Ubc9 (81) and S. pombe mutants lacking Aos1p 
homologue (38). Several important targets of SUMOylation in mitosis have been 
identified including the cohesin and condensin complexes, components of which are 
known to be SUMOylated further linking SUMOylation and mitosis (reviewed in 
(82)). Another critical substrate of SUMOylation during mitosis is DNA 
topoisomerase II (TopII) where mutants that lack SUMOylation are unable to 
undergo normal chromatid dynamics (reviewed in (36)). In yeast, SUMO E3 ligase 
mutants do not display strong mitotic phenotypes (reviewed in (82)). This may be 
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because E3 ligase are redundant in their function for key cellular protein, or it is 
possible that Ubc9 is able to catalyze SUMO transfer during mitosis. Such regulation 
of the cell cycle is not limited to the E1, E2 and E3 enzymes alone – the SUMO 
protease Ulp1 has also been identified to be necessary for passage through the cell 
cycle. Ulp1 mutants in budding yeast are delayed at the G2/M boundary and suffer 
from increased chromosome mis-segregation (51). Deletion of Ulp2 is not lethal but 
cells lacking Ulp2 lose chromosome and are hypersensitive to microtubule 
destabilizing drugs (78). 
During meiosis in yeast, SUMO is predominantly localized to synaptonemal 
complex (SC) and Zip3 which is a SUMO E3 ligase is crucial to initiating formation of 
the SC formation (84, 85). SUMO-mediated regulation of SC formation is a fairly 
conserved function across sexually reproducing organisms, but is absent from 
Tetrahymena. In higher eukaryotes such as mice and humans, SUMO localizes to 
specific regions of the chromatin that change as meiosis progresses (86, 87) 
suggesting that SUMOylation dynamically regulates proteins substrates throughout 
meiosis. In Drosophila, SUMOylation has been shown to modulate several 
developmental processes from wing morphogenesis, patterning of the eggshell and 
embryo to neurogenesis and metamorphosis which heavily indicates that 
SUMOylation is an important effector modification (reviewed in (88)). Several other 
in vivo studies have highlighted the importance of SUMO and its pathway proteins, 
Ubc9, PIAS and SENPs in embryonic development in numerous model systems 
(reviewed in (89)). 
21 
 
The SUMO Enigma 
At any given time, the amount of SUMO present in the form of SUMO adducts 
is lower than the free form of SUMO (90–93). In addition, SUMOylation appears to 
be a transient modification due to the action of SUMO proteases and as a result, 
SUMO-modified proteins do not persist in the cell for long periods of time (5, 94, 
95). These challenges make it difficult to investigate SUMO and its target proteins. 
The most important experiment in studying the modification of a protein by 
SUMO is in the identification of the site of attachment of SUMO protein on the target 
protein. While mutating the lysine residue that forms the isopeptide bond is a good 
test for confirming SUMOylation state, it may negatively affect other PTMs that may 
utilize the same residue. Gene knockouts, conditional mutants, overexpression and 
dominant-negative studies may prove useful in studying SUMOylation but 
appropriate controls have to be utilized.  
Herein the use of mass spectrometry-based proteomics approach that do not 
perturb the attachment sites of SUMOylation are extremely powerful and useful in 
the identification and characterization of SUMO substrates that exist as a smaller set 
of the total protein pool. An added advantage of these methods is the ability to 
identify several proteins at one time that give more insight into the SUMOylation 





Tetrahymena is a Model System for studying SUMOylation 
Ciliates are unicellular organisms that are characterized by presence of cilia 
on their cell surfaces and the presence of two nuclei unlike other eukaryotes. Each 
ciliate cell maintains both a transcriptionally inert germ-line micronucleus (mic) 
and a transcriptionally active somatic macronucleus (MAC). In the sexual life cycle, 
also referred as conjugation, two cells of different mating types pair together to 
initiate mating. In the early part of conjugation, the diploid mic in each partner will 
undergo meiosis to form haploid gamete nuclei. A single gametic nucleus will be 
transferred to another cell where it fuses with another gamete nucleus and form a 
zygotic nucleus. In the later stages of conjugation, broadly classified as MAC 
Differentiation, new progeny mics and MACs are derived from the zygotic nucleus 
(Figure 2) with the parental MAC degraded concomitantly. The new MACs (also 
termed anlagen) are derived from DNA amplification of the mic genome followed by 
genomic remodeling (reviewed in (96, 97)). The first type of type of genomic 
remodeling is chromosome breakage, in which the 5 chromosomes of the mic 
undergo ~50 breakages to form the ~250-300 acentric polygenomic chromosomes 
of the MAC. Chromosome breakage is a highly precise process with fragmentation of 
the chromosomes into smaller pieces and de novo addition of telomeres to newly 
broken ends (98, 99). The second type of genomic remodeling results in the 
elimination of mic-limited sequences from the anlagen. These sequences called 
internal eliminated sequences (IES) are removed by double-strand breaks in the 
DNA with the adjacent MAC-destined DNA being ligated back together (reviewed in 
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(100, 101)). It is now known that this type of DNA elimination in ciliates involves 
the same process of RNA-guided heterochromatin formation required for silencing 
of transposon elements in other eukaryotes (reviewed in (102, 103)). 
 
 
Figure 2. The sexual life cycle of Tetrahymena. In Tetrahymena, the diploid mic is 
transcriptionally silent and is responsible for germ-line functions. Conjugation 
(sexual reproduction) is a complex and dynamic process that starts cells pair (1-2 
hours). Following pair formation, the nuclei elongate to form “crescent” structures 
(3.5 hours) and then undergo meiosis during which genetic material is exchanged 
between partner cells (4-5 hours). A single meiotic product is selected for 
pronuclear exchange (5.5 hours) which then undergoes two post-zygotic divisions 
to generate two new mic and MACs (7 hours). The process of MAC development (7-8 
hours) involves extensive genomic remodeling and DNA amplification. When cells 
are returned to nutrient medium, they divide to generate daughter progeny (24-30 
hours). 
 
Tetrahymena is a useful model system for studying SUMOylation as a 
developmentally regulated process because it exhibits nuclear dimorphism – there 
is strong demarcation between somatic (MAC) and germ-line (mic) functions which 
makes it easy to study the vegetative and sexual life cycles separately. Mechanisms 
present in higher eukaryotes such as humans or other mammals that are either 
absent in other eukaryotic microbial model systems, or not as readily accessible in 
them as in Tetrahymena, are especially relevant. For example, lethal mutations can 
be harbored in the mic of a cell with a wild-type MAC that would presumably be 
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lethal in other model systems. The MAC genome has been sequenced and annotated 
and is comparable to that of multicellular organisms (104–106). Switching between 
the vegetative and sexual life cycles is as easy as mixing nutrient-starved cells of 
different mating types together. More importantly, the precise and tight regulation 
of nuclear processes that occur during conjugation provide a platform to study the 
various biochemical pathways that come into play during these critical processes. 
During MAC development the synchronized series of events in the new anlagen 
which include programmed DNA rearrangements in the form of site-specific DNA 
deletions (100, 106), de novo histone methylation (101), histone acetylation (107) 
and amplification of the MAC genome (100, 108) provide a dramatic and 
exaggerated series of biochemical events important in the nucleus. Genetic 
manipulations in Tetrahymena offer a natural complement to phenotypical studies 
for developing an overview of a pathway, and for identifying novel factors. A major 
challenge in current approaches to analyzing SUMOylation as a regulatory PTM is 
the low level of SUMOylated proteins (see The SUMO Enigma section above). The 
reasons for developing such a system in Tetrahymena are obvious - there are many 
model systems available for investigating the role of SUMOylation, however, few of 
them are amenable to studying the role of this PTM as they lack distinct 
developmental stages. An examination of the dynamic SUMOylation of substrates 
during these stages will reveal the role of low-level participating proteins. In this 
way, it will be possible to build functional links between the numerous substrates of 
Smt3p and the various developmental processes. We are interested in elucidating 
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the mechanism by which SUMOylation regulates programmed DNA rearrangements 
in the form of IES excision. The removal of these elements occurs in quite the 
dramatic fashion with approximately 6000 IES elements being excised followed by 
repair of resulting double strand breaks. This exaggerated phenomenon of IES 
excision occurs naturally as part of sexual life cycle of Tetrahymena and therefore 
provides a tremendous opportunity in studying the regulation of this process by 
SUMOylation. There are very few published studies that document the broad 
spectrum of proteins, involved in critical cellular processes, that are SUMOylated in 
response to different life cycles and herein Tetrahymena proves its versatility as a 
facile genetic model system.
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CHAPTER 2 – SUMOYLATION IS DEVELOPMENTALLY REGULATED AND REQUIRED 
FOR CELL PAIRING DURING CONJUGATION IN TETRAHYMENA 
 
Genetic analysis has revealed essential roles for SMT3 in the survival and 
development of organisms ranging in complexity from lower eukaryotes such as 
yeast to mammals. Studies of the loss of SUMOylation components function reflect 
the impact of SUMOylation on entire organisms. Mutants for SMT3 (SUMO), UBA2 as 
well as UBC9 have been reported for most developmental models from yeast and C. 
elegans to mouse. Although different phenotypes have been described for different 
species, these studies have demonstrated that components of the SUMOylation 
pathway are essential genes in these organisms. In S. cerevisiae, there is an absolute 
requirement for SMT3 in cell viability (33, 109). Deletion of SUMO pathway genes in 
the nematode C. elegans results in embryonic lethality, while downregulating the 
expression of SUMO conjugating enzyme Ubc9 in Drosophila, zebrafish, and mouse 
results in serious developmental defects (48, 81, 110). 
The Tetrahymena genome encodes a single form of SUMO (referred to as 
SMT3; Table 1) (111), which shares 49% and 48% sequence identity with human 
SUMO-1 and SUMO-2, respectively. SMT3 appears to have diverse roles inside the 
cell including, but not limited to, regulation of transcription, protein translation, 
DNA repair response, mitosis and meiosis etc. While SMT3 is present throughout the 
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two life cycles of Tetrahymena, cells undergoing MAC development during 
conjugation contain particularly high concentrations of Smt3p (112), suggesting 




Materials and Methods 
Strains and Culture Conditions 
Wild-type B2086 and CU428 strains of Tetrahymena thermophila were 
obtained from the Tetrahymena Stock Center, Cornell University, Ithaca, New York, 
USA. Strain B2086 contains 6-methly purine sensitive (MPR1) wild-type MACs with 
expression of mating type II. Strain CU428 contains 6-methyl purine sensitive 
(MPR1) wild-type MACs with expression of mating VII but contain micronuclei that 
have homozygous 6-methyl purine resistance (mpr1-1/mpr1-1). Wild-type and all 
other Tetrahymena strains were cultured in 1×SPP medium (2% proteose peptone, 
0.1% yeast extract, 0.2% glucose and 0.003% FeCl3) at 30 °C with shaking at 110 
rpm for vegetative growth. Smaller volumes (1-10 mL) did not require shaking. 
 
Mating Tetrahymena  
 For conjugation, T. thermophila strains were placed at 30 °C in 1×SPP and 
allowed to grow to logarithmic phase with an O.D.540 of 0.3 corresponding to 2×105 
cells/mL. Cells were then washed with Starvation Buffer (10 mM Tris, pH 7.5) and 
then subsequently starved (16-24 hours at 30 °C) in 10 mM Tris (pH 7.5). Equal 
numbers of cells of different mating types were mixed together to initiate mating. 
 
Construction of SMT3 and UBA2 germ-line knockout 
The targeting construct consisted of a neo3 cassette conferring paromomycin 
(pm) resistance placed under the control of the metallothionein (MTT1) promoter 
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(113). The drug resistance gene is flanked by sequences upstream and downstream 
of the SMT3 (5’ flank sequence was 1141 bp; 187801 to 188942 bp of scaffold 
8254555 and 3’ flank sequence was 1292 bp; 190002 to 191294 bp of scaffold 
8254555) or UBA2 coding sequence (5’ flank sequence was 1004 bp; 472623 to 
473627 bp of scaffold 8254719 and 3’ flank sequence was 1148 bp; 476286 to 
477434 bp of scaffold 8254719) (primers listed in Appendix Table 6). Wild-type 
B2086 and CU428 strains were then mated and the targeting construct was 
introduced at 2.5-3.5 hours post-mixing as described (114). Potential SMT3 and 
UBA2 micronuclear knock-out (KO) strains were identified by selection with 
paromomycin (confirming insertion of the neo3 cassette) and 6-methyl purine 
(6mp; confirming successful conjugation and formation of new macronuclei). The 
heterozygous mic KO strains were further analyzed by PCR and genetic crosses to 
test strains (e.g. CU427) to confirm germ-line segregation of paromomycin 
resistance. These heterozygous germ-line transformants were crossed with “star” 
strains B*VI and B*VII that are deficient in donating a functional micronucleus. The 
subsequent uniparental transfer that occurs resulted in the generation of 
homozygous germ-line knockout heterokaryon strains (115). The micronuclei 
(germ-line) in these cells have homozygous deletions of the targeted gene, but the 
MAC genome is wild-type because the two partners of “star” crosses do not proceed 
through conjugation to form new MACs. PCR analysis as well as genetic crosses 





To test the viability of the progeny of SMT3 or UBA2 homozygous 
heterokaryons strains, starved SMT3 or UBA2 heterokaryons strains (~2×105 
cells/mL) were mixed to initiate mating and mating efficiency was assessed at 2 
hours. Mating pairs were then isolated at 8-10 hours post-mixing in drops 
containing 1×SPP medium and placed at 30 °C. Cells in drops were examined at 
multiple times between 24 and 72 hours post-mixing. The number of cell divisions 
that occurred before death of homozygous SMT3 and UBA2 KO progeny was 
calculated by counting the total number of cells at the time of death, dividing by two 
(two exconjugants per pair) and calculating the cell divisions based on exponential 
growth. To determine successful completion of conjugation in SMT3 or UBA2 
heterokaryons, cells were cultured in 1×SPP containing 80 μg/mL paromomycin. 
Progeny of control cell lines wild-type B2086.2 × CU428.1 were also tested for 6-
methylpurine (7.4 μg/mL) resistance. Additional matings between SMT3 and UBA2 
heterokaryons to wild-type partners were also performed to ensure generation of 
viable progeny (Table 2). To check for progression through conjugation, cells were 
fixed and stained with DNA-specific dye diamidinophenolindole (DAPI) as described 
below (see Fluorescent and Confocal Microscopy). 
 
Creation of GFP-SMT3 and GFP-UBA2 constructs 
To examine Smt3p and Uba2p localization in Tetrahymena, coding regions for 
Smt3p and Uba2p were amplified and cloned into the pENTR/D-TOPO plasmid 
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(Invitrogen, Grand Island, NY), which is used for recombination with the Gateway 
cloning system, to create pENTR-SMT3 and pENTR-UBA2 respectively. LR Clonase II 
(Invitrogen, Grand Island, NY) was used for directional cloning of SMT3 or UBA2 into 
the destination vector pBSmttGFPgtw containing an N-terminal MTT1-inducible GFP 
expression cassette cloned upstream of a cycloheximide-resistant Tetrahymena 
rpl29 locus (described in (116)). For biolistic transformation, constructs were 
digested with HindIII or BlpI to produce linear plasmid with flanking rpl29 
sequences and transformed into starved Tetrahymena cells. Transformed cells were 
selected in SPP nutrient medium containing 12.5 μg/mL cycloheximide. To induce 
GFP-SMT3 or GFP-UBA2 expression, 0.1 μg/mL CdCl2 was added to vegetative and 
mitotic cells. For mating cells, 0.05 μg/mL CdCl2 was added when cells were first 
mixed and at 6 hours post-mixing. Cells were fixed as described below (see 
Fluorescent and confocal microscopy). 
 
Fluorescent and Confocal Microscopy 
GFP-SMT3 or GFP-UBA2 expressing cells were fixed with 4% 
paraformaldehyde for 30 minutes at room temperature, then washed with 1×Tris-
buffered Saline (TBS; 0.5 M Tris-Cl, 1.5 M NaCl, pH 7.6) for 10 minutes and stained 
with the DAPI at 1 μg/mL for 10 minutes. DAPI-stained cells were then placed on 
microscope slides and 5 µL of VectaShield Fluorescence Mounting Medium was 
applied to the cells. Fluorescent microscopy of vegetative strains expressing GFP 
transgenes (Figure 1) was performed using a Zeiss LSM 710 confocal microscope. 
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Digital images were processed using Zen 2009 (Carl Zeiss, Thornwood, NY) and 
Adobe Photoshop (Adobe Systems, Inc., San Jose, CA). Fluorescence images of mated 
cells (Figure 3) were obtained with an Olympus BX51TF model microscope and a 
40X objective oil lens (UIS2/BFP1; Olympus). 
 
Generating Conditional Mutants of SMT3 and UBA2 
UBA2 knockout heterokaryons of different mating types were mixed with 
each other to initiate mating. Cells undergoing MAC development (corresponding to 
8 hours post-mixing) were biolistically transformed using the MTT1 promoter 
expressed GFP-UBA2 transgene inserted at the rpl29 locus (cycloheximide 
resistance). Progeny that were successfully transformed (paromomycin resistant 
and cycloheximide resistant) were complete gene knockouts for wild-type UBA2 and 
expressed only the GFP-UBA2 form. SMT3 heterokaryons that were mated died in 
the first 24 hours after conjugation and we were unable to rescue cells using GFP-
SMT3 as described above. To generate a conditional mutant of SMT3, CU522 and 
CU527 strains that are sensitive to the drug paclitaxel (taxol; txs) were transformed 
with MTTp driven FLAG-His6-SMT3 construct (gift of Dr. Joshua Smith, Missouri 
State University) which was incorporated at the BTU1 locus resulting in progeny 
that are taxol-resistant (method originally described in (117)). FLAG-His6-SMT3 
expressing strains were further transformed with the neo3 construct used earlier to 
generate SMT3 KO heterokaryons. Cells were cultured in increasing concentrations 
of taxol and paromomycin to assort for FLAG-His6-SMT3 copies and the reduction of 
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wild-type SMT3. Complete assortment of the wild-type SMT3 gene away from the 
FLAG-His6-SMT3 copy was demonstrated by performing two-step Reverse 
Transcriptase-PCR (RT-PCR) on RNA obtained from FLAG-His6-SMT3 expressing 
strains which showed amplification of the FLAG-His6-SMT3 product only. 
 
Assessment of Pair Formation 
To assess pair formation, conditional mutants of SMT3 or UBA2 were 
cultured using three different conditions. The “+Cd” cultures were grown in SPP 
medium supplemented with 0.1 µg/mL CdCl2 for 24 hours at 30 °C. These cells were 
then starved in Starvation Buffer containing 0.1 µg/mL CdCl2 for 24 hours at 30 °C 
after which they were mixed to initiate mating pair formation. The “−Cd” cultures 
were grown and starved in the absence of CdCl2 and then mated to assess pair 
formation. The “+Cd Addition” cultures, were treated as described for the “−Cd” set 
except that 2 hours prior to mixing, cells were supplemented with 0.1 µg/mL CdCl2 
and then mated. The percentage of cells forming pairs was calculated as the number 
of cells in pairs divided by the total number of cells in the sample (paired plus single 
cells). 
 
Preparation of Whole Cell Extracts 
100 mL of vegetative wild-type strains B2086.2 and CU428.1 at log-phase 
(2×105 cells/mL) and mated cells (at 0, 2, 5, 7, 10, 24, and 30 hours post-mixing,) 
were harvested by centrifugation, washed twice with Starvation Buffer (10 mM Tris-
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Cl, pH 7.5) and then resuspended in 2 mL of lysis buffer (8 M Urea, 50 mM Tris, pH 
8.0) containing 50 mM N-ethylmaleimide and lysed by sonication. The resulting 
lysate was centrifuged at 4 °C for 30 min at 77,000×g in a SW41 rotor (Beckman 
Coulter). The clarified supernatant was then prepared for Western Blotting as 
described below. 
 
Western Blotting and Coomassie Staining Analyses 
Clarified lysates from wild-type strains were prepared by the addition of SDS 
loading buffer to a final concentration of 1× (50 mM Tris, pH 6.8, 10% glycerol, 2% 
SDS, 100 mM DTT, and 0.05% bromophenol blue). Samples were separated on 8% 
Bis-Tris Gels using Tris Glycine SDS running buffer and then transferred to PVDF 
membrane (Pall Corporation, Port Washington, NY) at 100 V for 2 h. Subsequent 
Western blot analysis was then performed with anti-Smt3p and horseradish 
peroxidase-conjugated secondary antibodies (Jackson Immunoresearch, West 
Grove, PA). Smt3p antibodies were custom generated by ProteinTech Group Inc. 
(Chicago, IL). Rabbits were immunized with a peptide corresponding to amino acids 
26-43 of Tetrahymena Smt3p (FFKIKKTTQFKKLMDAYC) and then antibodies were 
affinity purified from the resulting serum using the same peptide. Results were 
visualized with the ECL Prime chemiluminescence detection system (Amersham 
Biosciences, Piscataway, NJ). Coomassie staining was performed by first treating the 
SDS gel with fixing solution (10% glacial acetic acid and 25% isopropanol) for 3 
hours and then incubating it in Coomassie R250 staining solution (0.05% Coomassie 
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R250, 10% acetic acid and 25% methanol) overnight at room temperature. 






Tetrahymena Smt3p and Uba2p primarily accumulate in the macronucleus 
Previous studies on Paramecium tetraurelia revealed that RNAi induced 
silencing of UBA2 or SUMO resulted in the failure of programmed DNA 
rearrangements (111), but the underlying mechanism responsible for this effect was 
not established. Tetrahymena was selected for additional studies because of 
technical advantages (gene knockouts, higher mating efficiency) and the 
opportunity for comparative analysis with Paramecium. To initiate our analysis of 
SUMOylation we searched the Tetrahymena thermophila genome for homologs and 
identified a single gene encoding SUMO (118) with reciprocal top BLAST hits to 
SUMO proteins in S. cerevisiae, Drosophila and human. We named the Tetrahymena 
gene SMT3 (TTHERM_00410130) (111), consistent with S. cerevisiae nomenclature 
(Suppressor of Mif Two 3) (Table 1). The alignment of Tetrahymena Smt3p with 
human SUMO isoforms, S. cerevisiae, S. pombe and other protozoa is shown in Figure 
3A. Tetrahymena Smt3p shares 50% identity with S. cerevisiae. The N-terminal 
regions show substantial divergence, but most of the protein is highly conserved 
including the diglycine motif conserved in the C-terminus of most UBLs. A 
Tetrahymena homolog for UBA2 was previously reported based on its identity with 
Paramecium tetraurelia (TTHERM_00391590) (111). That study evaluated the 
developmental expression of transcripts from the Tetrahymena UBA2 and SMT3 
(SUMO) genes with northern hybridizations. Both showed substantial increases in 
expression during sexual reproduction, consistent with subsequent data from whole 
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genome microarrays (40). The developmental pattern of expression and sequence 
identity between these genes when compared with the previously examined 
Paramecium UBA2 and SUMO genes led us to perform additional studies. 
To evaluate whether the cellular location of Tetrahymena SUMOylation 
pathway proteins is consistent with Paramecium tetraurelia and other eukaryotes, 
we examined the localization of Smt3p and Uba2p. Localization of Smt3p and Uba2p 
during vegetative growth was examined by expressing GFP-SMT3 or GFP-UBA2 
transgenes from a metallothionein promoter regulated by cadmium. Both Smt3p 
and Uba2p were observed in the somatic MAC but not the germ-line mic in 
vegetative Tetrahymena (Figure 3B). Based on the coding sequence of SMT3, we 
generated rabbit polyclonal anti-Smt3p antibodies by immunizing animals with 
residues 21-43 of the full-length Tetrahymena Smt3p protein and used them to 
examine localization of Smt3p in vegetative cells (described in Materials and 
Methods). As seen in Figure 3C the predominant signal is in the macronucleus and 
no signal can be detected in the micronucleus. The signal at the cell cortex was 
detected with secondary antibody alone (no primary antibody) and is therefore 
unlikely to be significant. Additional experiments with the GFP transgenes showed 
that increasing or decreasing cadmium concentrations changed the strength of the 
GFP signal but did not alter its nuclear localization (data not shown). Although a 
small fraction of Uba2p and Smt3p are likely present in the cytoplasm we are 
confident that the signal is predominantly macronuclear in vegetative cells. Studies 
of other developmental model systems such as mice (22, 23), Drosophila (24, 25) 
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and yeast (26) have reported that both Smt3p and Uba2p localize predominantly to 
the nucleus. This is expected as many of the proteins modified by SUMO are nuclear, 
including promoter-specific transcription factors, DNA repair proteins and 
chromatin-associated proteins. Our results in Tetrahymena are consistent with the 
role of SUMOylation in somatic nuclear processes such as the regulation of 






Figure 3. Smt3p localizes to the somatic MAC during vegetative growth. (A) 
Sequence alignment of Smt3p isoforms from 7 species. Dark shading represents 
residues with highest percent identity across all sequences. Light shading indicates 
less conserved residues. The sequences and the accession numbers of Smt3p are as 
follows: H. sapiens SUMO-1, NP_003343.1; H. sapiens SUMO-2, NP_008868.3; H. 
sapiens SUMO-3, NP_008867.2; S. cerevisiae, NP_010798.1; S. pombe, NP_596035.1; 
P. falciparum, PFE0285c in PlasmoDB; O. trifallax, Contig18025.0.g12 in 
OxytrichaDB; P. tetraurelia, GSPATG00013187001 in ParameciumDB; and T. 
thermophila, TTHERM_00410130 in Tetrahymena Genome Database. (B) Nuclear 
localization of Smt3p and Uba2p during vegetative growth. GFP-SMT3 and GFP-UBA2 
constructs were transcribed from the metallothionein 1 promoter upon addition of 
cadmium. The GFP signal prominently localized in the somatic MAC but was absent 
from the germ-line mic (inset for the GFP-UBA2 is shown). (C) Immunofluorescence 
of log-phase wild-type cells treated with Tetrahymena polyclonal anti-Smt3p 
antibodies show that the signal is predominantly macronuclear. Cortical staining 
was observed in pre-immune controls (data not shown). Arrow-heads indicate MAC 




SUMOylation increases during conjugation in T. thermophila 
Anti-Smt3p antibodies used in Figure 3C were also utilized to determine 
SUMO expression throughout conjugation by western blot analysis. Figure 4A shows 
schematic representations of the stages when protein was prepared for analysis. 
Figure 4B shows a typical SUMOylation pattern with several reactive bands 
consistent with a range of proteins conjugated to Smt3p. The image is a short 
exposure to emphasize the difference in signal between vegetative cells and 
conjugating cells, but longer exposure show a large number of bands in the 
vegetative protein samples. The arrow head labeled Smt3p indicates the expected 
migration of free Smt3p. Experiments with high percentage gels (20%) showed that 
Smt3p migrates with a mass of approximately 13.5 kDa, but on the 10% gel shown 
in Figure 4B proteins below 20 kDa are not well resolved. A slightly higher apparent 
molecular mass than the theoretical molecular mass (11.4 kDa) of Smt3p is not 
surprising as SUMO proteins have been reported to exhibit anomalously slow 
migration on SDS-PAGE gels (1). The high molecular mass bands observed at the 40-
200 kDa range are Smt3p substrates that represent a diverse set of target proteins 
that are modified by Smt3p in vegetative and mating cells. In mating cells, we 
observed that Smt3p adduct formation increases as cells progress through 
conjugation with the highest signal observed between 7 and 10 hours post-mixing 
which corresponds to anlagen formation implicating SUMOylation in its role in MAC 
differentiation (Figure 4A and 4B). The bar graph in Figure 4C provides a 
quantitative assessment of the increased signal above 40 kDa relative to total 
41 
 
protein as measured by Coomassie staining. This increase in Smt3p signal is 
consistent with microarray expression data, which shows an increase in transcript 
levels during conjugation including anlagen formation (40). These results 
demonstrate that SUMOylation occurs differentially between vegetative and mating 





Figure 4. Differential modification of proteins by Smt3p during conjugation versus 
vegetative growth. (A) Schematic representation of the stages of conjugation at 
which cells were lysed. The following stages are shown: Pair Formation; Pronuclear 
Exchange; MAC Differentiation; Anlagen Formation; and Exconjugants. (B) Whole 
cell extracts (WCEs) were prepared from vegetative and mating B2086 and CU428 
wild-type cells at 0, 2, 5, 7, 10, 24, and 30 hours post-mixing. WCEs were analyzed 
by 10% SDS-polyacrylamide gel electrophoresis followed by Coomassie blue 
staining (for loading control; bottom panel) and Western blot using polyclonal anti-
Smt3p antibody (top panel). Arrow-head indicates the expected position of free 
Smt3p (~13 kDa) and high molecular weight proteins that are likely to be Smt3p 
conjugates. Coomassie stained gel is included as a control to evaluate equivalent 
sample loading. (C) The bar graph provides a quantitative assessment of the 
immunoblot signal across different time points after normalizing for sample loading 




To determine the cellular location of the increased Smt3p we performed 
immunofluorescence with the same anti-Smt3p antibody used in Figure 4. Mating 
cells were fixed at various times during conjugation leading up to the beginning of 
MAC development (9 hr). A low signal relative to background fluorescence masked 
specific localization in early stages of conjugation. As conjugation progressed, Smt3p 
was detected in parental MACs by the end of meiosis, and the antibody revealed a 
strong accumulation in the developing anlagen (Figure 5).  We also used the GFP-
Smt3p expressing strains (described in Figure 1) and found that Smt3p first 
localized to parental MACs early in conjugation and later accumulated in the 
developing anlagen which mimicked our results with the anti-Smt3p 
immunofluorescence analysis (Figure 5). Both techniques showed that the signal in 
the parental MAC disappeared as the anlagen developed and before the MAC was 
degraded. We did not detect Smt3p in the micronuclei or meiotic products during 
conjugation using anti-Smt3p or GFP-Smt3p. Although the GFP-Smt3p strains have 
the disadvantage of expression from the inducible MTT1 promoter, the consistent 
results using antibodies and GFP fusions give us confidence in our observations. 
In Paramecium GFP-Uba2p localized to the developing MAC (111). 
Antibodies against Tetrahymena Uba2p are not available for immunofluorescence, 
but GFP-Uba2p was expressed from the inducible MTT1 promoter in the absence of 
wild-type Uba2p (described in Materials and Methods). As shown in Figure 3, GFP-
Uba2p is located in the old MAC during the meiotic “crescent” phase (prophase I) of 
conjugation. The signal remains in the old MAC at later stages of meiosis and unlike 
44 
 
Smt3p, Uba2p is clearly visible in the meiotic products labeled “meiotic haploid 
products” in Figure 5. The signal is also detectable in haploid products during the 
period of pronuclear exchange (Figure 5). As the developing MAC (anlagen) appear 
they contain increasing Uba2p signal and the signal is simultaneously reduced in the 
parental (old) MAC. Consistent with our observations in vegetative cells, the signal 
is not detected in micronuclei at the two mic two MAC stage of development. 
Interestingly, Paramecium GFP-Uba2 expressed from its endogenous promoter 
showed little signal in the parental MAC and the primary signal appeared in the 
anlagen (111). The Tetrahymena Uba2p and Smt3p localization results (Figure 5) 
along with the immunoblot (Figure 4) are consistent with a major increase in 
SUMOylation of nuclear proteins during conjugation, particularly in the developing 
MAC. The absence of GFP-Smt3p localization in the meiotic products in contrast to 
the GFP-Uba2p localization to those structures is not readily explained, but it is 
clearly not an issue of protein abundance (the result was independent of the level of 





Figure 5. Localization of Uba2p and Smt3p in conjugation. UBA2 deletion cells were 
rescued with the MTT1-driven GFP-UBA2 construct to generate N-terminally tagged 
GFP-Uba2p expressing cells. Cells were mated and then fixed and stained with DAPI 
at various times throughout conjugation. GFP images were taken to visualize the 
distribution of UBA2 in mating pairs. GFP-SMT3 was transformed into B2086 and 
CU428 wild-type strains to produce N-terminal GFP-Smt3p tagged strains. The GFP-
Smt3p expressing strains were mated and fixed at time-points shown in the figure. 
Smt3p localization was also visualized in mated wild-type cells using anti-Smt3p 
antibodies. A schematic of nuclear morphologies as observed in wild-type mating is 
drawn for reference. The following developmental stages are observed: “crescent” 
micronuclei (prophase meiosis I) (4 hr); meiotic haploid products generated after 
completion of meiosis II (5 hr); pronuclear differentiation and exchange (6 hr); 
second post-zygotic mitosis (7 hr); and macronuclear anlagen formation and 
nuclear processing (9 hr). Arrow-heads indicate selected anlagen, arrows indicate 
selected mic. 
 
Complete Deletions of SMT3 and UBA2 Result in Cell Lethality 
In budding yeast and invertebrates such as the nematode Caenorhabditis 
elegans, there is a single SMT3 gene which is essential for viability (28, 29). 
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Deletions in the SUMO-activating enzyme UBA2 or the SUMO-conjugating enzyme 
UBC9 are lethal in the budding yeast (32, 33, 79), C. elegans (119), A. thaliana (120) 
and in mouse (81). In Paramecium tetraurelia, RNAi silencing of UBA2 or SUMO had 
no detectable effect on vegetative cells but arrested conjugating cells. To test 
whether SMT3 and UBA2 are essential genes in Tetrahymena, we generated 
micronuclear (germ-line) deletion strains that were subsequently mated to produce 
complete (mic and MAC) deletions. The initial heterozygous mic knockout strains 
were selected with paromomycin after transformation with knockout (KO) 
constructs containing the neomycin resistance cassette (neo3) flanked by sequences 
upstream and downstream of each coding regions (Figure 6A). The resulting 
heterozygous knockout cells were cultured without paromomycin selection to allow 
phenotypic assortment of the drug resistant (KO) alleles and identification of 
paromomycin sensitive cells with fully wild-type MACs. These heterozygous 
knockout cells were mated with “star” strains containing defective micronuclei and 
wild-type MACs. These crosses result in abortive conjugation, in which paired cells 
complete meiosis and exchange genetic material, but separate without making new 
macronuclei. These post-conjugation cells emerge with homozygous micronuclei, 
but retain their original MACs genetically wild-type for SMT3 and UBA2 (Figure 6A 
and 6B) (115). Phenotypically these cell lines are paromomycin sensitive, but we 
used PCR amplification to identify the strains homozygous for the neo3 cassette in 
place of the corresponding coding region in the micronucleus (Figure 6C). These 
homozygous heterokaryon knockout strains of SMT3 or UBA2 were then mated and 
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individual pairs were isolated to nutrient medium. Analysis of >100 pairs from each 
cross revealed that the majority of pairs failed to survive (Table 2). Pairs that did 
survive were tested for paromomycin-resistance to determine whether they were 
true exconjugant progeny or pairs that aborted conjugation. This test was used 
because the parental strains were phenotypically paromomycin-sensitive (MAC 
genotype) but their germ-line micronuclei were homozygous for paromomycin 
resistance. The formation of a new MAC would result in paromomycin resistance. As 
indicated in Table 2, none of the surviving lines were paromomycin resistant and 
most likely they were abortive mating pairs containing wild-type MACs. Control 
crosses of the same knockout heterokaryon strains with wild-type cells (B2086 or 
CU428) resulted in high survival (~93 %) of true exconjugant progeny that were 
paromomycin resistant. This demonstrates that the knockout heterokaryons contain 
fertile micronuclei. The data are consistent with a lethal phenotype for complete 
deletions of SMT3 or UBA2. This has been reported in other organisms and we 





Figure 6. Generation of SMT3 and UBA2 knockout heterokaryons. (A) Schematic 
drawings of SMT3 and UBA2, their targeted loci, the knockout construct as well as 
the resulting gene knockout formed by homologous recombination. The entire SMT3 
and UBA2 coding sequences were replaced by insertion of the neo3 knockout 
cassette that confers paromomycin resistance. Arrows indicate the locations of 
primers used for genotyping PCR from total DNA. (B) To generate Tetrahymena with 
homozygous deletions in the mic, a type of abortive mating called round I genomic 
exclusion was utilized wherein wild-type cells were crossed with ‘star’ strains that 
have defective micronuclei. Star strains are able to form mating pairs with wild-type 
cells but do not provide a migratory gametic micronucleus to the wild-type partner 
following meiosis. The single haploid micronucleus that is donated by the wild-type 
partner to the star partner, then undergoes endoreplication, to form a homozygous, 
diploid micronucleus in each conjugant. At this point, the mating pair aborts 
conjugation and separates. (C) Total DNA isolated from wild-type CU428 (lane 6), 
SMT3 (lanes 1-4; top panel) and UBA2 (lanes 1-4; bottom panel) knockout 
homozygous heterokaryons was PCR amplified with primers shown in (A). Positions 
of the bands for the disrupted (KO) loci as well as wt genes are indicated. Genotypes 
of SMT3 and UBA2 homozygous germ-line knockout heterokaryon strains and wild-
type strains are illustrated at the top. Lane 5 in both gels contained the 
corresponding KO construct as template. 
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Interestingly, there was a substantial difference in the timing of post-
conjugation death for ΔSMT3 and ΔUBA2 strains. ΔSMT3 progeny died before the 
first post-zygotic cell division, but ΔUBA2 progeny died much later, 6-8 cell divisions 
after mating (~72 hours post-isolation). Clearly UBA2 expression is not required 
from the zygotic macronucleus (anlagen) to complete conjugation. The SMT3 and 
UBA2 knockout heterokaryon crosses were monitored by DAPI staining to detect 
any grossly aberrant nuclear events (i.e. meiosis, pronuclear fusion, mitotic 
divisions and anlagen development), but none were detected. The ΔUBA2 vegetative 
progeny have the normal distribution of 1 MAC and 1 mic prior to death. The ΔSMT3 
progeny arrest in conjugation at the 2 MAC, 2 mic stage, but the events prior to that 
appear normal (data not shown). We also examined the ΔSMT3 progeny and ΔUBA2 
progeny for defective programmed DNA elimination. Using a PCR strategy 
developed previously (116) we examined DNA from cells at the time of mixing (time 
0) and 24 hours later from several hundred conjugating pairs collected after mixing 
the same culture. A total of five eliminated DNA elements were examined for each 
cross. The results for the M and R elements in ΔSMT3 progeny are shown in 
Appendix Figure 15. For each eliminated element the product expected for accurate 
DNA processing was detected and there was no evidence for the inhibition of DNA 
elimination. The explanation for the shorter life span of ΔSMT3 cells compared with 






Table 2. SMT3 and UBA2 are essential genes. 
















ΔSMT3-neo3-1 × ΔSMT3-neo3-2 110 34 0 
ΔUBA2-neo3-1 × ΔUBA2-neo3-2 124 32 0 
ΔSMT3-neo3-1 × B2086 110 91 81 
ΔUBA2-neo3-1 × B2086 110 96 88 
ΔSMT3-neo3-2 × CU428 110 89 84 
ΔUBA2-neo3-2 × CU428 110 92 83 
B2086 × CU428 88 82 82 
aEach row represents data obtained in the course of three independent experiments. 
bTo distinguish between cells that completed conjugation (progeny cells) and cells 
that have aborted conjugation, wild-type B2086 and CU428 strains were tested for 
resistance with 6-methyl purine (only progeny cells should be resistant) and cells 
from the ΔSMT3-neo3 × ΔSMT3-neo3 and ΔUBA2-neo3 × ΔUBA2-neo3 mating were 
checked for paromomycin resistance (progeny should be paromomycin resistant). 
 
Gene Rescue with MTT1 Promoter Converts the SMT3 or UBA2 Deletion Lines into 
Conditional Mutants 
As SMT3 and UBA2 are essential genes, complete deletions resulted in cell 
death making it difficult to obtain information on the null phenotype of these genes. 
This problem was circumvented by the creation of conditional mutants of SMT3 and 
UBA2 in which the expression of these genes could be regulated by addition of CdCl2 
to culture medium. As ΔUBA2 progeny survive for up to 72 hours post-mixing, the 
parental UBA2 heterokaryons were mated en masse and at 8 hours post-mixing 
(corresponding to formation of new anlagen), mating cells were biolistically 
transformed with the GFP-UBA2 construct (placed under MTT1 control) to rescue 
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the lethal phenotype (Figure 7A). The only expressed functional copy of the UBA2 
gene in these cells was the GFP-UBA2 transgene under MTT1 control. For ΔSMT3 
mated cells, we were unable to rescue the lethal progeny with the GFP-SMT3 
transgene, possibly due to insufficient expression of the introduced copies at the 
end of conjugation. To bypass this issue, we generated Tetrahymena cell lines that 
were somatic transformants expressing introduced FLAG-His6 epitope tagged SMT3 
(also driven by the MTT1 promoter) at the BTU1 locus in CU522 and CU725 strains. 
Incorporation at the BTU1 locus in these strains confers resistance against the drug 
taxol (paclitaxel) that are otherwise taxol-sensitive. Next, we transformed these 
FLAG-His6-SMT3 expressing strains with the neo3 knockout construct that replaces 
the endogenous SMT3 gene and then cultured cells in increasing concentrations of 
paromomycin and taxol to select for cells in which wild-type copies of SMT3 had 
been assorted out and only FLAG-His6-SMT3 remained as the functional copy 
(Figure 7B and C). Reverse transcription PCR was used to confirm the absence of the 
wild-type SMT3 transcript (Figure 7C). To determine whether placing SMT3 and 
UBA2 under the control of the MTT1 promoter would lead to a conditional, Cd-
regulated mutant, we examined the growth rates of these cell lines compared to that 
of wild-type strains. The growth rate of the conditional strains is similar to that of 
wild-type cells when the culture medium is supplemented with cadmium, but 
significantly slower when these strains are cultured in cadmium-free medium 
(Figure 7A and B). The difference between the lethal phenotype of the complete 
gene deletion strains and the slow growth phenotype of the conditional cell lines in 
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the absence of cadmium can be explained by “leaky” expression of the MTT1 
promoter even in the absence of cadmium. This has been reported previously (113) 
and we have seen this in our own analysis of MTT1 promoter constructs. These 
results demonstrate a conditional phenotype in the absence of CdCl2 that is 





Figure 7. Tetrahymena expressing the GFP-UBA2 or FLAG-His6-SMT3 transgene 
regulated by the MTT1 promoter behave as conditional mutants. (A) Schematic 
drawing of ΔUBA2 homozygous heterokaryon strains that were mated and 
transformed with the GFP-UBA2 transgene regulated by the MTT1 promoter and 
inserted at the rpl29 locus. The resulting UBA2 conditional cell lines and wild-type 
CU428 strains were grown vegetatively and transferred into 10 mL of SPP medium 
at an initial concentration of 200 cells/mL with either 0.1 μg/mL cadmium or no 
cadmium. At 0, 4, 8, 12, 20, 24, and 48 hours after placement in growth medium, 
cells were fixed and scored using a hemocytometer. (B) ΔSMT3 homozygous 
homokaryon progeny were lethal within 24 hours. Schematic drawing shows the 
transformation of CU522 strain with MTT1-FLAG-His6-SMT3 at the BTU1 locus. The 
same strain was then transformed with the neo3 knockout construct (MTT1 
promoter) disrupting the endogenous SMT3 gene. These conditional SMT3 cells 
were scored for growth as described in (A) above. (C) RT-PCR reactions to detect wt 
SMT3 transcripts in conditional mutants. The locations of the primers (arrows) used 
to amplify regions from the cDNA are shown on the left. Lanes 1, 2, and 3, on the gel 
correspond to PCR reactions using the primer sets (1, 2, and 3) indicated on the 
diagrams to the left. No wt SMT3 transcript is detected in the SMT3 conditional 
mutant cell line. 
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SMT3 and UBA2 requirement in mating pair formation in conjugating cells 
We know from previous studies in Paramecium tetraurelia that silencing UBA2 
results in conjugation arrest during MAC development (111). Using our conditional 
Smt3p and Uba2p cell lines we tested the effect of Smt3p or Uba2p depletion on 
conjugation in Tetrahymena. Conditional mutants of different mating types were 
cultured overnight in nutrient medium with or without cadmium to either promote 
or reduce expression of SMT3 or UBA2 transgenes respectively. Each culture was 
washed and cultured in starvation buffer for 24 hours under the same plus (+Cd) or 
minus cadmium (−Cd) conditions. Two hours before mating, 0.1 µg/mL of cadmium 
was added to a flask containing a portion of the cadmium free culture (referred to as 
“+Cd Addition” cells). Wild-type cells were carried through the same procedure 
under the same conditions. Cells from cadmium and non-cadmium treated cultures 
were mated separately. Cells were evaluated at 2 hours and 8 hours post-mixing for 
pair formation and cell samples were DAPI stained to examine the nuclear events 
during conjugation. Smt3p and Uba2p conditional mutant cultures that had not been 
exposed to cadmium were unable to form mating pairs (Figure 8). In contrast, the 
conditional mutants that had been exposed to cadmium had greater than 70% pair 
formation and progressed normally through the nuclear events of conjugation (data 
not shown). Smt3p and Uba2p conditional cells that were cultured without 
cadmium, but treated with cadmium two hours prior to mating were able to form 
pairs and progress through the normal nuclear events of conjugation as assayed by 
DAPI staining (Figure 16). The finding that conditional cells can recover their ability 
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to pair clearly demonstrates a dependence on Smt3p and Uba2p expression 
immediately prior to conjugation, and eliminates the possibility that cells do not 
pair as a result of defective nuclei or other damage that could occur during 
vegetative growth. Wild-type control cells, both cadmium and non-cadmium treated, 
showed greater than 80% pairing and normal progress through conjugation as 
expected (Figure 8). The non-pairing phenotype of Uba2p and Smt3p depleted cells 
was unexpected and prevents the use of these cell lines to examine later stages of 
conjugation. Nevertheless, the elevated expression of SUMO pathway proteins and 






Figure 8. Depletion of Smt3p and Uba2p results in inability to form mating pairs. (A) 
Work flow for assaying formation of mating pairs in SMT3 and UBA2 conditional 
mutants. Strains of different mating types for each genotype were cultured with 
(+Cd) or without (–Cd) cadmium to early log-phase, then starved in Starvation 
Buffer with the corresponding plus or minus cadmium condition (see Materials and 
Methods for details). A portion of each –Cd culture was supplemented with 0.1 
μg/mL cadmium two hours prior to mating, these cultures are referred to as “+Cd 
Addition”. Cells were then mixed to initiate mating. (B) At 8 hours post-mixing, cells 
were fixed and scored using a hemocytometer to calculate mating efficiency. SMT3 
and UBA2 conditional mutants cultured in cadmium-deficient conditions (–Cd) were 
unable to form mating pairs and did not progress through conjugation. Cells from 
+Cd cultures or –Cd cultures that were supplemented with cadmium two hours 
prior to mixing (+Cd Addition) formed mating pairs. Solid white bars represent 
wild-type (wt) cells, grey bars represent SMT3 conditional mutant (Smt3p) and 
hatched bars represent UBA2 conditional mutant (Uba2p). Error bars (standard 
error) are shown. 
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Smt3p and Uba2p deficient strains are sensitive to DNA damaging agents 
Generation of conditionally mutant strains further allowed us to examine 
possible roles of this modification. Studies in budding yeast have shown increased 
DNA damage sensitivity correlated with reduced SUMOylation (121–123). Multiple 
studies in mammals show Smt3p modification of DNA repair proteins enhances the 
repair response (75, 76). To test whether Tetrahymena relies on SUMOylation-
mediated DNA repair, we treated Smt3p and Uba2p conditional cell lines with the 
DNA-damaging agents: methyl-methanesulfonate (MMS) that causes cell cycle arrest 
and cisplatin that cross-links DNA causing cell cycle arrest and induces apoptosis in 
yeast and mammalian cells (124–126). Wild-type, Smt3p conditional lines and 
Uba2p conditional lines were cultured in the presence or absence of cadmium. Cells 
were treated with either MMS or cisplatin, and then placed in drops with cadmium 
(0.1 μg/mL) for 24 hours to evaluate cell survival. In the absence of cadmium, Smt3p 
and Uba2p conditional mutants showed lower survival against MMS and cisplatin 
compared with the same cells cultured with cadmium (Figure 9). This increased 
survival after cadmium exposure occurs despite the negative effect of cadmium on 
wild-type cell survival (Figure 9). This finding suggests that SUMOylation enhances 
the DNA damage repair response in Tetrahymena as it does in other species. The 
role of increased SUMOylation in conferring resilience to DNA damage in conditional 
mutants is consistent with a role for SUMOylation during the programmed DNA 





Figure 9. Smt3p and Uba2p depleted cell lines are sensitive to DNA damaging agents. 
SMT3 and UBA2 conditional mutants growing in the absence or presence of 
cadmium (1 µg/mL) were treated with DNA damaging agents MMS (4.5 mM) and 
cisplatin (2 mM). For each condition 216 single cells were isolated into drops with 
medium supplemented with 0.1 µg/mL cadmium and incubated at 30 °C for 48 
hours. Drops containing ≥500 cells were scored as viable and drop containing ≤10 
cells were counted as unviable. Viability is expressed as percentage of viable drops 
out of total number of drops. B2086 was used as the wild-type control. Error bars 






Developmentally regulated SUMOylation during conjugation in Tetrahymena 
Global increases in SUMOylation are known to result from exposure to 
environmental conditions or specific reagents, for example hydroxyurea, heat shock 
or ethanol (47, 59, 76). In contrast, few examples of large developmentally regulated 
increases in SUMOylation have been reported. Our study reveals that the sexual 
cycle of Tetrahymena is one such example. Immunoblot analysis of whole cell 
extracts revealed differential modification of substrates by Smt3p between 
vegetative and mating Tetrahymena cultures (Figure 4). Smt3p increased as 
conjugation progressed with the highest Smt3p signal observed during MAC 
differentiation stage. This increase is consistent with elevated SMT3 and UBA2 
transcript levels in conjugating cells compared with vegetative or starved cells 
(111). Our immunofluorescence studies also showed that Smt3p is predominantly a 
nuclear protein during the MAC development stage (Figure 5). Together, the 
immunoblot and immunofluorescence data suggest a requirement for protein 
SUMOylation inside the developing MAC. During this period extensive genome 
remodeling occurs including heterochromatin formation, transcriptional regulation, 
DNA replication and DNA repair (96, 108), processes that have known connections 
to SUMOylation in other species. In addition, our previous study of UBA2 and SUMO 
genes in Paramecium revealed elevated transcript levels for both during 
conjugation. RNAi generated knockdowns arrested conjugating cells and inhibited 
programmed DNA elimination (111). While the nuclear events in Tetrahymena and 
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Paramecium are dramatic, other reports of global changes in SUMOylation are 
known. During mouse spermatogenesis two distinct expression profiles of SUMO 
isoforms were detected, one during meiosis and the other in post-meiotic 
spermatids suggesting an important role for SUMOylation in spermiogenesis (86). A 
recent study in human keratinocyte differentiation also highlights SUMOylation as a 
regulator of cell differentiation. In these cells, SUMO expression was upregulated by 
calcium signaling at both the RNA and protein level, while degradation of SUMO 
activating and conjugating enzymes resulted in abnormal differentiation of these 
cells demonstrating key roles for SUMOylation in the keratinocyte differentiation 
process (127). 
 
The SUMO pathway is conserved in Tetrahymena 
Despite the dramatic changes in SUMOylation in Tetrahymena we find that 
most features of the pathway are conserved with other eukaryotes. As expected 
based on other species, the localization of Smt3p and Uba2p is predominantly 
nuclear (reviewed in (1)). In vegetative Tetrahymena cells both Smt3p and Uba2p 
localized to the somatic MAC (Figure 3). Interestingly we did not observe a GFP-
Uba2p or GFP-Smt3p signal in the mic nor did we detect the loss of mics in our 
conditional cell lines. We examined more than 50 cells during various stages of 
mitosis and could not detect a GFP-Smt3p signal from the micronucleus (data not 
shown). We cannot claim that Smt3p is completely absent from the mic, but our data 
support a much lower concentration in mics than in MACs during vegetative growth. 
61 
 
As true for other eukaryotes, UBA2 and SMT3 are essential genes. We generated 
germ-line deletions of SMT3 and UBA2 genes using homologous recombination. The 
deletions were carried in the mics of heterokaryon cell lines that express wild-type 
SMT3 and UBA2 from the somatic MAC. The progeny of these heterokaryon cells 
have complete deletions of SMT3 or UBA2 and die following conjugation (Table 2). 
This lethal phenotype is consistent with the deletion of SUMO and UBA2 genes in 
yeast (32, 33) and mammalian model systems (81). Interestingly, our earlier work 
with the ciliate Paramecium showed that RNAi knockdowns of SMT3 and UBA2 had 
no effect on vegetative growth (111). In retrospect this lack of vegetative phenotype 
is likely due to incomplete knockdowns providing a low level of SMT3 and UBA2 
expression. As observed for other eukaryotes, Tetrahymena Smt3p and Uba2p 
depleted cell lines were hypersensitive to DNA damaging agents. When we treated 
Tetrahymena with MMS or cisplatin, cells depleted for Smt3p and Uba2p showed 
increased sensitivity to both DNA-damaging agents (Figure 9). Several proteins 
involved in DNA repair are SUMO substrates or proteins that interact with 
components of the SUMO pathway (75, 76, 128). Examples include DNA repair 
proteins such as PCNA (122), 53BP1 and MDC1 (75) and XRCC4 (128). 53BP1 and 
MDC1 localize along with SUMO proteins to sites of double strand breaks that occur 
as a result of DNA damage (75). XRCC4, an important protein in the mammalian 
NHEJ pathway, depends upon transient SUMOylation for localization to the nucleus 
(128). The NHEJ pathway is believed to be the key mechanism for repair of dsDNA 
breaks generated during programmed DNA rearrangements that occur naturally 
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during conjugation in ciliates (129). In Paramecium tetraurelia the RNAi induced 
silencing of ligase IV (a partner of XRCC4 in NHEJ) during conjugation results in the 
persistence of free broken ends during genome reorganization (130). The increasing 
links between NHEJ pathway proteins and genome reorganization during ciliate 
conjugation suggests potential targets for SUMOylation. The increased sensitivity of 
conditional Smt3p mutants to DNA-damaging agents along with the accumulation of 
Smt3p and Uba2p in the MAC anlagen is consistent with a role for SUMOylation 
during MAC differentiation in ciliates. 
 
SUMOylation pathway is required for cell pairing 
When we reduced Uba2p expression levels in conditional mutant strains by 
withdrawing cadmium, the cells were unable to form mating pairs. The same 
conditional strains growing in the presence of cadmium proceeded through 
conjugation normally as did wild-type cells. Although this result was unexpected, 
there is precedence for SUMOylation dependent effects on mating. In the budding 
yeast, SUMO-modification of transcription factor Ste12 is stimulated by mating 
pheromone thus increasing its half-life and committing the cell to the mating 
differentiation program (131). In addition, turnover of the yeast mating type factor, 
α1 protein, is dependent on SUMO-targeted ubiquitin ligases SLX5 and SLX8 which 
is consistent with the involvement of SUMO-mediated pathways (132). In our 
system, the inability of Smt3p and Uba2p deficient Tetrahymena cells to form pairs 
could result from altered gene transcription, modified signaling pathways or direct 
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SUMOylation of the mating type protein. The experiments presented here do not 
allow us to distinguish between direct and indirect SUMO-mediated effects but the 
recent identification of the mating type protein from Tetrahymena provides an 
opportunity to test some of these possibilities in the future (133). The dramatic 
upregulation of SUMOylation in Tetrahymena coupled with the defined events of 
genome alteration (heterochromatin formation, DNA elimination, DNA replication) 
make this a rich system for analysis of SUMOylation function and dynamics. 
Although the cell-pairing defect prevented the use of these lines to analyze defects 
at later stages of conjugation, we expect strong phenotypes during macronuclear 
development. Efforts are currently focused on developing alternative approaches 
such as inducible RNAi knockdowns of SUMO pathway genes and identifying 
SUMOylated proteins specific to conjugation for further analysis. 
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CHAPTER 3 – PROTEOMIC STRATEGY TO IDENTIFY SMT3P SUBSTRATES IN 
TETRAHYMENA  
 
Early in the study of SUMOylation, most substrates were identified by chance 
when immunoblot analyses revealed slower migrating bands that were unexpected. 
Prior to 2004, the list of known Smt3p substrates had been compiled mostly by 
chance discovery of SUMO modification on proteins of interest and direct candidate 
analysis which most commonly involves epitope tagging of proteins purported to be 
SUMO-modified and use of immunoblotting to confirm the SUMOylation state of 
these proteins. Proteomic-based methods are increasingly useful in the 
identification and validation of proteins modified by UBLs such as SUMO because 
they offer high throughput and are far less labor-intensive than testing the 
SUMOylation status of individual proteins. The most common approach involves 
expression of tagged SUMO proteins followed either by single or double affinity 
purification (reviewed in (92)). The use of immunoprecipitation (as one of the 
affinity purification steps) is becoming very common because it utilizes specific 
interactions between the antibody-coupled matrix and epitope-tagged SUMO 
protein (134). Following the affinity purification steps, protein samples are resolved 
by SDS-PAGE and then digested with a protease to yield short peptide fragments. 
Peptides are further separated using by High Performance Liquid Chromatography 
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(HPLC) and eluted peptides are injected into the mass spectrometer (MS) 
instrument. Inside the instrument, the peptides are ionized and are directed to the 
mass analyzer, which separates them on the basis of their mass-to-charge ratio 
(m/z). The most commonly used method in the detection of UBLs is tandem MS 
(also indicated as MS/MS) where primary intact peptides fragment into intense ions 
that are selected for a second round of ionization, collision and detection. This 
generates a series of peptidic fragments that have characteristic m/z values that are 
used to construct the peptide sequence of the parent ion. In the final stage MS data is 
analyzed by matching the experimentally observed m/z values of each peptide with 
the theoretical ones contained in a database. The in silico digest of the peptides is 
done by peptide-search engines such as Mascot, Sequest and X!Tandem which will 
look for shifts in the mass values due to addition of PTMs on protein substrates 
(reviewed in (93)). There are issues with proteomics-based approach in the 
identification of the SUMO proteome namely, low-stringency purifications, which 
means fewer actual protein substrates than desired are immunopurified, and 
ineffective protease inhibition which results in removal of the Smt3p moiety from 
the protein substrates resulting in loss of the tag as well as general degradation of 
proteins. As a result, methods that address these two primary concerns prove very 
useful in the enrichment of SUMOylated substrates from a complex biological 
mixture. Therefore, we used a denaturing cell lysis to prevent deSUMOylation of 
substrates followed by two-step affinity chromatography coupled with HPLC-
MS/MS analysis for identification of SUMOylated substrates. Our data revealed 
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SUMO-modified proteins controlling chromatin structure, gene expression, 




Materials and Methods 
Generation of Tetrahymena expressing His6-3FLAG epitope-tagged SMT3 
The double epitope construct consisted of a hexahistidine (His6) tag followed 
by a triple FLAG (3FLAG; FLAG tag sequence is DYDDDK) tag preceding SMT3 gene. 
The tagged construct was inserted into the unique BsiWI and ApaI sites of 
pBSYFP2_gtw plasmid (Douglas Chalker, Washington University, St Louis)  under 
the control of the MTT1 promoter along with a selectable marker in the form of a 
mutant rpl29 gene that confers cycloheximide resistance via homologous 
recombination. The tagged Smt3p construct was introduced into wild-type B2086 
and CU428 strains as described (22). Cells successfully transformed with the His6-
3FLAG-SMT3 construct were selected with cycloheximide (12.5 μg/mL). Individual 
cells were isolated in drop medium to establish colonial cell lines that were 
subsequently induced with 0.1 μg/mL CdCl2 and confirmed by Western Blot analysis 
for expression of the His6-3FLAG-Smt3p construct. For control experiments, wild-
type untagged strains were used.  
 
Purification of Smt3p Conjugates 
Tetrahymena strains containing His6-3FLAG-SMT3 were inoculated at 1000 
cells/mL and grown in 500 mL of SPP medium to early log-phase (2×105 cells/mL) 
at 30 °C in a platform shaker (110 rpm). Cells were harvested at room temperature 
in 250 mL spin bottles (Corning, Corning, NY) by centrifugation at 2,250 rpm in a J2-
MC High-Performance centrifuge (Beckman Coulter, Indianapolis, IN). Cells were 
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then washed once with 100 mL of Starvation Buffer (10 mM Tris-Cl, pH 7.5) and 
then pelleted using the same conditions as the initial harvest. The pellet was 
resuspended in 10 mL of lysis buffer (8 M Urea, 100 mM Na2HPO4-NaH2PO4, 10 mM 
Tris-Cl, 5 mM imidazole, pH 8.0) containing 50 mM N-ethylmaleimide (NEM) and 
protease inhibitors (final concentrations of 10 μg/mL chymostatin, 5 μg/mL 
leupeptin, 12.5 μg/mL antipain, and 10 μg/mL E-64). The resulting whole cell 
extract (WCE) was immediately placed on ice and further lysed by 15X pulses of 
sonication (50% power, output setting 7) using a Misonix XL-2015 sonicator 
(Qsonica, Newtown, CT). The WCE was clarified by centrifugation at 4 °C for 1 hour 
at 25,000 rpm in a SW41 rotor (Beckman Coulter, Indianapolis, IN) and then further 
clarified by passage through Miracloth (EMD Millipore, Billerica, MA) placed inside a 
10 cc syringe. The filtered lysate (10 mL) was incubated with a 250 μL slurry of Ni-
NTA resin (QIAgen, Valencia, CA) for 24 hours in a rotator at 4 °C. The resin was 
washed for 10 minutes with 10 mL each of Wash Buffer A (8 M Urea, 100 mM 
Na2HPO4-NaH2PO4, 10 mM Tris-Cl, pH 8.0), Wash Buffer B (8 M Urea, 100 mM 
Na2HPO4-NaH2PO4, 10 mM Tris-Cl, 0.2% Triton X-100, pH 8.0) and Wash Buffer C (8 
M Urea, 100 mM Na2HPO4-NaH2PO4, 10 mM Tris, 0.1% Triton X-100, pH 8.0). Wash 
buffers were removed from columns by gravity flow (bottom stoppers opened). 
Bound proteins were eluted 3X with 1.5 bed volumes of Wash Buffer A 
supplemented with 250 mM imidazole resulting in a total volume of ~600 µL. The 
elution fraction was then diluted to 10 mL with cold TBS (50 mM Tris, 150 mM NaCl, 
pH 7.5). The diluted sample was then incubated with 100 µL of anti-DYDDDK 
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agarose (GenScript, Piscataway, NJ) at 4 °C for 24 hours. Beads were then pelleted 
by centrifuging at 1,000 rpm in a J2-MC High-Performance centrifuge (Beckman 
Coulter, Indianapolis, IN) for 1 minute. Beads were transferred to 1.7 mL microfuge 
tubes and then washed with 1 mL of TBS by rotating at 4 °C for 10 minutes. Wash 
steps were repeated 3X times. Beads were pelleted after each wash by spinning at 
1000×g in a mini centirfuge. TBS Proteins were eluted twice with 250 μL of alkaline 
triethylamine (100 mM, pH 12.0). The control protein preparation for this 
experiment was prepared in the exact same manner, except untagged wild-type 
Tetrahymena strains were utilized. 
 
Western Blotting and Coomassie Staining Analyses 
To evaluate expression of the tagged SUMO lysates from the His6-3FLAG-
Smt3p and control wild-type strains were prepared for SDS-PAGE by addition of 4X 
SDS loading buffer (63 mM Tris, pH 6.8, 2% glycerol, 2.3% SDS, and 0.05% 
bromophenol blue) supplemented with 100 mM dithiothreitol (DTT) to a final 
concentration of 1X. Protein samples were incubated for 5 min in a 95 °C heating 
block before loading on 8% Bis-Tris acrylamide gels (27.5:1 bis-acrylamide ratio) 
using Tris-Glycine SDS running buffer. SDS-PAGE gels were electrophoresed at 100 
V for 2 hours. For Western Blotting, proteins were transferred to PVDF membrane 
under wet conditions (Pall Corporation, Port Washington, NY) at 147 V for 1.5 
hours. Western blot analysis was then performed with initial probing with anti-
FLAG primary antibodies (Sigma, St. Louis, MO) prepared as a 1:10,000 dilution in 
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5% skim milk. Primary antibody incubation was performed overnight on a platform 
shaker at 4 °C. Following this, membranes were probed with horseradish 
peroxidase-conjugated secondary antibodies (Jackson Immunoresearch, West 
Grove, PA), also prepared as a 1:10,000 dilution in 5% skim milk, for 1 hour at room 
temperature. The membranes were incubated with Luminata Crescendo detection 
reagent (EMD Millipore, Billerica, MA) for 2 minutes at room temperature. Results 
were visualized with the ChemiDoc Imager (Bio-Rad, Hercules, CA) using the default 
program for western blotting. Coomassie staining of Bis-Tris acrylamide gels was 
performed by first fixing the gel in fixing solution (10% glacial acetic acid and 25% 
isopropanol) for 3 hours and then staining with Coomassie R250 staining solution 
(0.01% Coomassie R250 and 10% acetic acid) overnight at room temperature. 
Destaining (10% glacial acetic acid) was done for 3-6 hours with gentle rocking. 
 
In solution Trypsin Digestion and Protein Fractionation  
Eluates from the second round of purification using FLAG resin were pooled 
together and digested with trypsin (1:100 enzyme:protein ratio; Piercenet, 
Rockford, IL) at 37 °C for 24 hours. The tryptic digestion was quenched by addition 
of 0.1% trifluoroacetic acid (TFA). Peptide preparations were individually loaded 
onto C18 resin (Thermo Scientific, Waltham, MA) and separated using a 35-min 





Mass Spectrometry Acquisition and Database Search 
Eluted peptides were then directly entered into an ESI QuadTOF mass 
spectrometer (TripleTOF 5600; AB Sciex, Concord, Canada). The instrument was 
coupled with an Eksigent Nano LC-2DPlus with nanoFlex cHiPLC electrospray 
ionization (ESI) system (Eksigent, Dublin, CA). The sample acquisitions were 
performed using a “trap and elute” configuration on the nanoFlex system. The trap 
column (200 m 0.5 mm) and the analytical column (75 m 15 cm) were packed with 
3 m ChromXP C18 medium. Samples were loaded at a flow rate of 2 nL/min for 10 
minutes and eluted from the analytical column at a flow rate of 300 nL/min in a 
linear gradient of 5% solvent B (95% acetonitrile, 0.1% formic acid, v/v) to 35% 
solvent B in 90 min. The column was regenerated by washing with 80% solvent B 
for 10 minutes and re-equilibrated with 5% solvent B for 10 minutes. For standard 
data-dependent analysis experiments, the mass spectrometer alternated between 
acquiring a full 250-ms scan (TOF-MS) and subsequent MS/MS spectra of the 50 
most abundant precursor ions with a 50-ms scan. The selection criteria for parent 
ions included intensity, where ions had to be greater than 100 counts/s with a 
charge state between +2 to +4 and were not present on the dynamic exclusion list. 
Once an ion had been fragmented by MS/MS, its mass and isotopes were excluded 
for a period of 6 s. Ions were isolated using a quadrupole resolution of 0.7 Da and 
fragmented in the collision cell using collision energy ramped from 15 to 45 eV 
within the 50-ms accumulation time. In the instances where there were less than 20 
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parent ions that met the selection criteria, those ions that did were subjected to 
longer accumulation times to maintain a constant total cycle time.  
Data were analyzed using the Tetrahymena Genome Database (TGD) 
<http://ciliate.org/> in conjunction with the Mascot v2.5 search algorithm (Matrix 
Science, Boston, MA). MS searches allowed for a search tolerance of 10 ppm for the 
peptide mass tolerance and 0.2 Da for the MS/MS tolerance. The enzyme selected 
for protease digestion was trypsin with 2 missed cleavages specified. The charge of 
the peptides to search was set to +2, +3 and +4. Initial peptide filtering was done at 
an FDR of 1% and proteins were required to have 2 or more peptides identified at 
the 1% FDR level. The MS spectra were searched against a reverse database to 
estimate the false discovery rate. Figures and tables of the identified proteins were 
made using information from both the TGD and UniProt 
<http://www.uniprot.org/>. Finally, the sequences of identified proteins were 







Affinity Purification of Smt3p Conjugates from Tetrahymena 
The main challenge in identifying Smt3p substrates is the low abundance of 
protein substrates relative to the total protein in the cell. In addition, SUMOylation is 
often a short-lived and transient modification which means that few proteins in the 
cells are likely to be SUMOylated. The use of two rounds of purification serve to 
enrich for SUMOylated substrates for identification in the mass spectrometer. To 
determine the catalog of SUMO proteins (the SUMOome) in vegetative cells, we used 
a two-step affinity purification followed by HPLC-coupled MS protein identification. 
The dual tag construct consisted of the N terminal 6His tag followed by a 3FLAG tag. 
We used the MTT1 promoter for cadmium-based induction of the tagged Smt3p 
(Figure 10A). The construct was transfected in Tetrahymena strains at the rpl29 
locus that confers resistance against the drug cycloheximide. It should be noted that 
these cells also express wild-type Smt3p from the endogenous locus. As shown in 
Figure 10C expression of the tagged Smt3p was cadmium dependent. A low 
concentration of cadmium (0.1 μg/mL CdCl2) was used to induce the expression of 
the dual-tagged 6His-3FLAG-Smt3p protein, to avoid inundating the cell with excess 
Smt3p protein. The tagged Smt3p was detected in its non-conjugated (free) form at 
approximately 14 kDa but the majority of signal was located in higher mass regions 





Figure 10. The psYFP2_His6-3FLAG-SUMO vector and its expression product. (A) A 
map of the plasmid encoding His6-3FLAG-Smt3p construct that was used to 
transfect wild-type Tetrahymena strains. (B) Schematic representation of the dual 
epitope tag containing the N-terminal His6 epitope tag and the second 3FLAG 
epitope tag. Target proteins are conjugated at the C-terminus of Smt3p. For 
immunoblotting analyses, antibodies directed against the 3FLAG epitope tag were 
used. (C) Immunoblotting of the whole cell extract (WCE) prepared from His6-
3FLAG-Smt3p expressing strain and wild-type untagged strain. Expression of His6-
3FLAG-Smt3p is driven by the MTTp promoter. Growth medium was supplemented 
with 0.1 μg/mL CdCl2 to induce the expression of the tagged form of Smt3p. Free 
Smt3p is indicated with an arrow head at ~14 kDa. The high molecular weight 
region containing numerous proteins that are likely to be Smt3p substrates is also 
indicated with a bracket. Low amounts of cadmium were used to minimize 
overexpression which contributes to non-typical conjugation of protein substrates 
by Smt3p. 
 
In the first round of affinity purification, the His6 tagged was bound to Ni-
NTA agarose under strongly denaturing conditions (containing 8 M urea) in order to 
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solubilize the majority of cellular proteins by denaturation as well as to ensure that 
proteins identified in the proteomic screen are directly conjugated to Smt3p. The 
lysis buffer also contained NEM and protease inhibitors to inhibit the activity of 
SUMO proteases from removing Smt3p from substrates. A single round of 
purification is not recommended when purifying UBL substrates as it has been 
shown to result in a large number of false positives (109). This is especially the case 
with Ni-NTA purification as many proteins bind non-specifically to this resin in 
yeast (45, 109, 135). In order increase the purity of the sample, a second 
purification step was performed with anti-FLAG resin. Following incubation with 
anti-FLAG resin, proteins were eluted under highly alkaline conditions (100 mM 





Figure 11. Overview of the double affinity purification and identification of His6-
3FLAG-Smt3p tagged proteins. (A) The two-step affinity purification workflow is 
described in more detail in the Materials and Methods section of this chapter. The 
actual procedure of the double-affinity purification includes additional steps such as 
culturing and lysis of the cells, denaturation and renaturation of the proteins, and in 
solution digestion with trypsin and database searches. (B) Fractions from Ni-NTA 
purification were collected after each step during purification as the crude cell 
extract (CR), flow through (FL), elution (E), and beads (B). Samples were loaded 
proportionally and resolved by SDS-PAGE (10% gel). Fractions from untagged wild-
type strain are on the left half (lanes 1-4) while proteins from the tagged Smt3p 
strain are on the right (lanes 5-8). Smt3p conjugates and free Smt3p protein are 
indicated. 
 
Identification of SUMOylated Substrates by LC-MS/MS 
Eluted samples from the two-step purification were digested in solution with 
trypsin. The resulting peptides were extracted and loaded onto a reverse-phase 
column and eluted with increasing concentrations of acetonitrile (ACN) directly into 
the mass spectrometer. We chose a QuadTOF mass spectrometer to identify the 
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protein substrates because this instrument has high sensitivity and accuracy. The 
mass spectrometer was configured to acquire both accurate mass (MS) and 
sequence (MS/MS) information for the eluting peptides. We used Mascot algorithm 
to identify the peptides against a conceptual translation of Tetrahymena gene 
sequences from Tetrahymena Genome Database (TGD) and Uniprot. Proteins that 
were included in our list of SUMO substrates had to meet two criteria: 1) they must 
be unique to the Smt3p immunoaffinity purification (not in the untagged cell 
purification) and 2) they must be identified by 2 or more peptides (Table 3 and 
Table 7). Proteins that were identified in the control wild-type untagged sample 
were eliminated from the tagged Smt3p substrate dataset even if they met the 
criteria stated above for MS search. Proteins in the untagged cell sample could be 
highly abundant proteins that were carried over during the two purifications. As 
predicted from the above-mentioned immunoblot, little overlap was observed 
between the datasets of the tagged Smt3p and untagged purifications. 
 
Analysis and Categorization of SUMOylated Substrates 
A total of 153 proteins were identified from five independent runs in the 
His6-3FLAG-Smt3p purification (full list available in Appendix Table 7). We 
identified numerous novel proteins as Smt3p substrates as well as others that have 
been previously identified (Table 3). Many of these proteins are orthologous to well 
characterized SUMO substrates found in other organisms. For example, 
Heterochromatin Protein 1 (HP1) is a SUMO substrate (136, 137) and the ribosomal 
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protein Rps17 has been purified from a SUMO proteomic screen in Drosophila (48) 
(Table 3).  
 




TGD ID References 
SUMOylation Machinery    
Smt3p* 10.2 TTHERM_00410130 (138, 139) 
Ubc9p* 24.0 TTHERM_00522720 (140) 
Metabolic Enzymes    
Gpm1* 31.6 TTHERM_00641240 (141, 142) 
Cit1* 63.6 TTHERM_00529790 (143) 
Pgi1* 63.6 TTHERM_01108700 (45) 
Tcb2 24.7 TTHERM_00068170  
Ribosomal Proteins    
Rpl20 29.2 TTHERM_00476670  
Rpl43 11.4 TTHERM_00075670  
Rps11 18.1 TTHERM_01109770  
Rps17* 14.9 TTHERM_00762890 (48) 
Rack1* 38.5 TTHERM_01113100 (144) 
Chromatin-Associated    
HTA3* 15.3 TTHERM_00143660 (145) 
TGP1* 83.4 TTHERM_00499420 (146) 
HP1* 44.2 TTHERM_00245410 (136, 137) 
Cytoskeleton Structure    
DFB1 48.1 TTHERM_00128280  
TTNA 98.9 TTHERM_00006320  
MYO2 210.9 TTHERM_01035740  
Other    
ATP2 53.4 TTHERM_00585260  
Hsp60* 61.6 TTHERM_00196370 (147) 
PRE10* 27.6 TTHERM_00487110 (109) 
Liver F-Antigen 46.0 TTHERM_00678260  
*Previously identified as SUMO substrates in other species. 
 
We compared our tagged Smt3p dataset with separate studies in S. cerevisiae 
(45), D. melanogaster (48) and A. thaliana (148) that utilized a similar two-step 
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affinity purification (Figure 12). There was only one protein in common with the 
Arabidopsis study and this is likely due to the fact that affinity purification in that 
study yielded only 20 proteins.  A total of 11 proteins were common between 
Tetrahymena and Drosophila and 16 proteins were common in the purifications 
from Tetrahymena and yeast. There are 3 proteins that are common all three 
purifications. The presence of Tetrahymena proteins in purifications from 
Drosophila and yeast adds confidence to these proteins as authentic Smt3p 
substrates. 
 
Figure 12. Comparison of SUMO substrates identified using 2-step purification in 
various model systems. Tagged Smt3p dataset from two-step purification in 
Tetrahymena were compared to the same from purifications from Drosophila and S. 
cerevisiae. Three proteins are common between all three organisms making them 
highly likely to be true Smt3p substrates. 
 
In a separate study, tagged Smt3p conjugates were isolated under native 
conditions using the same two-step affinity purification scheme, and 141 protein 
substrates were identified (Qianyi Yang and James Forney unpublished). There is 
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some overlap between this dataset and the one described above where Smt3p 
conjugates were isolated under denaturing conditions (Figure 12). These protein 
substrates that were purified from both lysis conditions are considered high 
confidence Smt3p targets (Table 8). 
 
 
Figure 13. Overlap between Smt3p substrates purified under denaturing and native 
conditions. All proteins reported to be SUMOylated in our proteomic screen using 
denaturing conditions were manually extracted and compared to those found by MS 
using native conditions. Proteins considered in the denaturing lysis purification 
analysis are included in the Table 7 and proteins common to both lysis conditions 
are presented in Table 8. 20 proteins are purified from both lysis conditions 
indicating that these proteins are high confidence protein substrates of Smt3p. 
 
 In an attempt to gain insights into the functions of potential Smt3p substrates 
identified in our proteomic screen for vegetative Tetrahymena, we used the 
Tetrahymena Genome Database (TGD) and the Uniprot Knowledgebase to categorize 
these proteins based on their subcellular localization (Figure 14A) and biological 




Figure 14. Graphical representation of both the cellular location and biological 
function of Smt3p candidate substrates. (A) We used the Tetrahymena Genome 
Database (TGD) and the Uniprot Knowledgebase to categorize the identified 
substrates based on cellular location. As expected, many of these proteins are 
nuclear proteins. However, a surprisingly high number of these proteins that are 
present in the cytosol and/or localized to other non-nuclear organelles. (B) These 
same database sources were also utilized to graphically represent the diverse 
functional categories (Gene Ontology terms) to which these identified SUMOylated 
substrates belong. The largest such category was found to be comprised of proteins 
involved in metabolism which suggests that SUMOylation is not highly centralized in 
the nucleus. However, SUMOylation clearly plays a role in other biological 
phenomena, including DNA-related processes, protein translation and folding, 
crosstalk with other PTMs etc. As in the case of Figure 14A, there are many proteins 
with unknown function and as more information is made available in the TGD, the 
fraction of proteins categorized as such is likely to decrease. 
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From this analysis, a few conclusions can be made. Firstly, as expected the 
largest localization category is the nucleus (25% of proteins identified in our study 
are predicted to reside in the nucleus). Both yeast and fruit fly have a higher 
percentage of nuclear substrates, 43% and 33% respectively. Second, we also 
observed a large percentage of proteins that are predicted to be cytosolic, or 
associated with other organelles which would suggest that SUMOylation is a less 
nuclear centralized process than previously thought. For example, 22% of the 
proteins were localized in soluble fractions while 13% and 9% are found in the 
ribosome and mitochondrion respectively. It is plausible that some of the identified 
non-nuclear proteins may translocate to the nucleus upon modification by Smt3p. A 
third conclusion is that protein substrates of SUMOylation belong to broad and 
diverse range of biological processes which is expected for this important PTM. In 
addition to DNA-related processes (15% in Tetrahymena), a substantial number of 
proteins in other cellular processes were also identified as targets of SUMOylation. 
For example, numerous proteins in Tetrahymena are involved in various metabolic 
pathways (23%) and the same is the case in Drosophila (28%). We also observed 
several proteins (14% in Tetrahymena) that play a role in protein translation (as 
part of the larger ribosome complex) similar to both yeast and Drosophila. Other 
processes include crosstalk with PTMs (9%), response to cellular environment (3%) 
and structural maintenance (3%). Interestingly, components of the SUMO pathway 
such as the E2 conjugating enzyme Ubc9p and Smt3p protein itself were observed in 
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our proteomic screen consistent with similar observations in other systems (Table 
3) (149–151). 
For novel candidate SUMOylated substrates, we searched the amino acid 
sequences using SUMOsp2.0 (152) for matches to a SUMO target consensus 
sequence (ψKXE) present in many SUMOylated proteins (reviewed in (2)) (Table 4). 
While SUMO conjugation of substrates does not always occur at SUMO consensus 
motifs in previously identified cases (reviewed in (42)), presence of these motifs 
suggests strong candidate lysines in the substrates that might be modified and, 
hence, a starting point for subsequent site-directed mutagenesis studies aimed at 
identifying the biological effect of SUMOylation in desired target proteins.  
 
Table 4. Consensus Smt3p target sites. 
Identified Proteins 
Smt3p Consensus Site 
(ψKXD/E) 
Heterochromatin protein 1 VKWE, VKQD, VKQE 
CHROMOdomain protein 2 VKRE 
C2H2 (zinc-finger protein) PKIE, IKKE 
Ubiquitin-60S VKHD 
Phosphoglycerate mutase 1, 
GPM1 
KKQE 
HSP70 FKVE, LKDE 
HSP60 LKGE 
SSA5 (DnaK protein) FKVE, MKDE 
CIT1 LKHE 
ATP synthase MKVE, LKFE 
RACK1 FKVE 
Sd2e domain protein IKQE, LKQE, LKHE 
Ubc9p LKQE, LKDE 






Sequence analysis also revealed that our SUMOome contains a comparable 
number of ψKXE SUMO modification consensus motifs per protein to that contained 
in previously reported SUMOylation targets from other species (Table 5). The wild-
type internal rejects (untagged strain) list contains almost three-fold fewer SUMO 
consensus sites per protein than the His6-3FLAG-Smt3p proteome (0.6 versus 2.2) 
and is similar to the fraction in the total Tetrahymena proteome (0.6 versus 0.8) 
(Table 5). 
 
Table 5. Frequency of Smt3p consensus sites in known SUMO target proteins 
compared with this study. Smt3p modification consensus sites of the form ψKXE 














Published Smt3p substrates 265 517 49 2.0 
His6-3FLAG-Smt3p proteomea 60 132 64 2.2 
Tetrahymena proteome 16,102 12,771 9,440 0.8 
Wild-type internal rejectsb 37 21 9 0.6 
aProteins identified in this study 





Our proteomic screen employed double-affinity purification coupled to mass 
spectrometry (MS) to identify protein substrates. This approach generates 
improved purity and lower background than single affinity purifications. In 
experiments where Smt3p substrates were purified utilizing a single round of 
purification (45, 109, 135), many of the identified proteins were also purified from a 
mock untagged strain which would suggest that a single round of purification do not 
produce a pure sample for use in MS. Using a double-affinity purification scheme is 
then more suited for identifying Smt3p substrates as it yields cleaner sample and 
control preparations.  
A second important feature of our approach that adds confidence to our 
SUMOome dataset is the use of a QuadTOF mass spectrometer for the collection of 
the MS/MS spectra. The advantage of this particular instrument is its high 
sensitivity (femtomoles). This is critical because only a small fraction of total 
proteins in the cell are SUMOylated at any given time. The high sensitivity of the LTQ 
mass spectrophotometer is helpful then, to identify the low amounts of SUMO-
modified peptides. 
We concede that even with our careful controls, there are likely to be some 
Tetrahymena proteins that may be falsely identified as Smt3p substrates. An 
example of this would be the heat shock proteins that we identified in only one 
experiment; these proteins may have been purified because of stress suffered by 
cells immediately prior to lysis. Other examples could be some of the ribosomal 
86 
 
proteins as well as proteins involved in heavy-metal metabolism which may have 
been identified in our proteomic screen because we used cadmium-driven MTT1 
promoter for expressing the tagged Smt3p. Despite using denaturing conditions (8 
M urea) for lysis of cells, it is possible that some of the proteins identified in our 
proteomic screen are carried through the double-affinity purification because they 
form highly stable complexes with protein substrates that are attached to Smt3p. 
These concerns can be addressed by immunoblotting studies with antibodies 
against protein substrates to confirm the SUMOylation state of these proteins 
and/or by identifying lysine sites of Smt3p attachment (See Future Directions). 
The more obvious targets of Smt3p in our proteomic screen are nuclear 
proteins that are involved in gene expression. Many of these protein substrates play 
a role in chromatin remodeling, transcription and mRNA processing (Table 3). This 
is consistent with a role of SUMOylation as a predominantly nuclear process 
(reviewed in (2)).  
Our proteomic screen did not provide full coverage of the entire SUMOome. 
This is evident by the fact that we did not identify proteins such as topoisomerase II 
(4) and RanGAP1 (153) which are well known Smt3p substrates in yeast. 
Optimization of the double-affinity procedure to minimize high abundant sticky 
proteins may help in getting a purer sample. A possible solution is to separate the 
nuclei from the cell using differential centrifugation and analyze the nuclear extract 
using mass spectrometry. Lastly, it is possible that these well-known Smt3p 
substrates are low abundance proteins in Tetrahymena making it difficult to carry 
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these proteins over two purification steps. While our proteomics screen did not 
cover the entire SUMOome, we were able to identify several novel protein 
substrates of SUMOylation in Tetrahymena such as the ER protein, TCB2 and the 
deep-fiber bundle protein, DFB2. Similar studies have been performed in mammals, 
Drosophila and yeast using similar proteomic approaches (45, 46, 48) where full 
coverage of the SUMOome was not achieved. It may require multiple runs as well 
other proteomic approaches to produce a more comprehensive list of Smt3p targets. 
 
SUMOylation in DNA-related Processes 
Many protein substrates of SUMO are nuclear proteins with important roles 
in the regulation of transcription, maintenance of chromosome and chromatin 
structure and DNA repair (reviewed in (154, 155)). The effect of SUMOylation on 
transcription factor activity generally leads to repression as opposed to Ub-
modification which tends to result in transcriptional activation (reviewed in (154)). 
As observed in proteomics studies in yeast (45) and mammals (156), the largest 
group of proteins identified in SUMO proteomic screens were involved in DNA-
related biochemical processes. The same trend was observed in our proteomic 
screen. Chromatin proteins such as the histone H2A variant (HTA3) were identified 
as Smt3p substrates. Another nuclear protein (TTHERM_00245410) that contains a 
CHRromatin Organisation MOdifier (CHROMO) domain was also captured five times 
in our proteomics screen. This is a homolog of a heterochromatin protein 
(HP1/CBX1) in mammals that recognizes and binds histone H3 tails that are 
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methylated at Lys-9 (H3K9) leading to a heterochromatic state through epigenetic 
repression (136). It is known to interact with SUMO-1 in affinity-capture 
experiments (137). One proposed model is that SUMOylation of CBX1 causes the 
protein to localize to the nucleus. Mutants that cannot be SUMOylated are unable to 
localize in nuclear domains and are instead found dispersed throughout the cell 
(136).  
As many of the SUMOylated proteins identified to date are transcription 
factors, coactivators, or corepressors that associate with DNA (reviewed in (89, 91, 
154)), it is not surprising that our affinity purification captured several nuclear 
protein substrates highlighting the importance of this PTM in DNA-related 
processes. Transcriptional factors and other chromatin-associated proteins such as 
histones have been demonstrated to be modified by other PTMs such as 
phosphorylation, acetylation, methylation, and ubiquitylation (reviewed in (154)). 
As a result, analysis of SUMOylation-dependent changes in chromatin dynamics is 
undoubtedly made complicated by the fact that many of the enzymes that regulate 
chromatin structure are themselves modified by several PTMs. Identification of 
proteins involved in DNA-associated processes as Smt3p substrates aids in 





SUMOylation directs Ribosome Maturation 
The control of ribosome biogenesis is a critical process which ensures that 
protein synthesis is coordinated with cell growth and proliferation. Several 
proteomic studies aimed at identifying SUMO substrates have shown that ribosomal 
proteins and trans-acting factors have been identified as potential Smt3p substrates 
in various model systems (45, 48, 109, 157). We too, identified numerous ribosomal 
subunit proteins that are part of the greater ribosomal complex in our proteomic 
screen - RpS4, RpL15, RpL23, RpL4, RpL18, RpL22, RpL40, and RpL36 were all 
purified as Smt3p substrates. The presence of several ribosomal subunits would 
suggest that the multi-protein ribosomal complex often contains multiple 
SUMOylated proteins (Table 3 and Table 7) some of which possess several predicted 
sites of Smt3p attachment (Table 4). It is not entirely clear why so many ribosomal 
proteins are substrates of SUMOylation. Smt3p could be part of a nuclear 
surveillance system that ensures proper protein translation. Indeed, under 
conditions of stress that require increased protein translation for stress response, 
an overall increase in SUMOylation is observed which may help in ribosomal 
maturation, assembly and function (47, 76). This role of SUMOylation is supported 
by mutation studies where inhibition of SUMOylation affects ribosome export (157). 
The ribosomal protein RpL40, involved in regulation of protein translation, was also 
identified as a substrate of Smt3p. RpL40 has two components - ubiquitin and 
ribosomal 60S subunit. The Ub component of RpL40 is believed to facilitate the 
assembly of the ribosomal protein into ribosomes upon export to the nucleus (158). 
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In a recent study, investigators used a specific protease inhibitor as a way of 
inhibiting the activity of SENPs proteases in prostate cancer cells stably expressing 
SUMO (159). A combination of stable isotope labeling with amino acids (SILAC) 
quantitative proteomic technique was used to identify more than 900 putative 
target proteins of SUMO, one of which was RpL40 (159). Regulation of RpL40 by 
Smt3p modification may shed light on the mechanism underlying prostate cancer 
progression.  
As demonstrated in Table 3, our work provides a few examples of clustering 
of SUMOylation in the ribosomal complex. The high degree of incidence of this 
phenomenon in our data strongly indicates that substrate clustering may be an 
important mechanism by which SUMOylation regulates large protein complexes. An 
alternate model of Smt3p regulation may be that it regulates cellular processes by 
targeting macromolecular complexes rather than individual proteins as typical of 
other posttranslational modifications. Such coordinated SUMOylation could function 
to localize an entire protein complex to a specific subcellular location or stabilize the 
protein complex by inhibiting modification by Ub. Clearly, additional work aimed at 
elucidating the functional strategy underlying this mechanism will provide 






SUMO in Metabolic Homeostasis 
 The first identified targets for SUMO modification were mostly nuclear 
proteins (reviewed in (82)). However, more recent studies have identified a number 
of cytoplasmic Smt3p targets (reviewed in (160, 161)). Extra-nuclear roles of 
SUMOylation have been described in regulation of G protein signaling, 
phosphorylation crosstalk, mitochondrial fission/fusion, glucose transport as well 
as regulation of neuronal integrity and synaptic function (41, 162, 163). In some 
cases SUMOylation regulates master proteins to affect entire metabolic pathways 
(reviewed in (160)). Phosphoglycerate mutase 1 (GPM1) (Table 3), which 
participates in the glycolysis cycle, was identified as an interacting partner of Smt3p 
through a bimolecular fluorescence complementation assay in yeast (141). The 
same protein, GPM1, was also identified as a SUMO substrate in a separate 
proteomics screen in yeast (164). In Drosophila, a genome-wide screen to 
systematically search for modulators of citrate synthase (CS) identified Smt3p as an 
active regulator of the CS enzyme (143). Flies that are SMT3 heterozygous mutants 
have increased CS activity, providing additional support for SUMOylation in 
regulating mitochondrial function. Considering that SUMOylation greatly influences 
protein activity, stability and protein interactions, it is not surprising that 







RNAi based knockdown of SUMOylation pathway genes 
The role of SUMOylation in regulating diverse critical processes in the 
eukaryotic cells is well documented (reviewed in (2, 82, 91)). We observed that 
there is an increase in the levels of Smt3p during Tetrahymena thermophila 
conjugation (Figure 4). Conditional mutants of Smt3p and Uba2p, in which Smt3p 
and Uba2p was depleted, were unable to form mating pairs and therefore could not 
progress through conjugation. This non-pairing phenotype prevented us from 
analyzing the requirement of SUMOylation during conjugation. To circumvent this 
issue, we can use an RNAi-based approach to knockdown the levels of SUMOylation 
pathway genes. Previous studies in another ciliate Paramecium tetraurelia 
demonstrated that RNAi-based silencing of Smt3p and Uba2p inhibited the excision 
of IES elements during the macronuclear development stage of conjugation in this 
organism (111). We anticipate that RNAi-mediated downregulation of SUMOylation 
pathway genes in Tetrahymena will lead to a similar phenotype with cells arresting 




Identification of SUMOylation sites on protein substrates 
An alternate approach to study the requirement of SUMOylation during 
conjugation (or vegetative life cycle for that matter) is to identify and alter 
SUMOylated substrates. We intend to employ a MS-based approach to identify the 
catalogue of proteins that are modified differentially by Smt3p in response to the 
sexual life cycle and the various stages therein. Proteomics approaches which aid in 
identification of sites of SUMOylation are especially helpful in this case as they yield 
useful information for mutational analyses where sites for Smt3p attachment can be 
inactivated in protein substrates. To this end, we have generated a Tetrahymena 
strain expressing Smt3p V85K that can be used in conjunction with mass 
spectrometry to map SUMOylation sites on purified proteins. It is technically 
challenging to identify sites of SUMO attachment to protein substrates because 
common proteases such as trypsin generate long SUMO peptides attached to target 
lysines that add to the mass of the peptide and are subject to fragmentation during 
MS/MS. The resulting fragmentation patterns in the mass spectrum are very 
complex and cannot be easily interpreted by conventional MS algorithms. The 
Smt3p mutant with V85K mutation leaves a GG remnant on target lysine residues on 
substrates when affinity-purified substrates are subjected to protease digestion 
with Lys-C. In this case, the MS instrument can be configured to detect the specific 
mass shift because of attachment of the diglycine remnant to proteins substrates 
(46). Preliminary data shows that we have identified SUMOylated lysine residues on 
several proteins from both vegetative and mated Tetrahymena Smt3p V85K strains. 
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For protein substrates of Smt3p identified earlier that are not purified using the 
V85K mutant, we will have to use in vitro and/or in vivo methods to confirm their 
SUMOylation status. 
 
HP1 and HTA3 as potential Smt3p substrates 
A CHROMO domain-containing protein related to Heterochromatin Protein 1 
(TTHERM_00245410, here referred to as HPR) was identified in our two-step 
purification procedure in Tetrahymena (Chapter 3). HP1 was also identified as a 
SUMO target in yeast. The hinge domain of murine HP1 has been demonstrated to 
be modified by SUMO (136). In this particular study, the authors observed that de 
novo SUMOylation of HP1 targets the protein to pericentric heterochromatin. 
Microarray expression profile shows that the levels of HP1 in Tetrahymena are 
upregulated during conjugation with the peak during MAC development (~3-fold 
higher than vegetative growth). We know that major regions of the genome in the 
developing macronucleus for heterochromatin before their elimination. My model 
for the role of HP1 in MAC development involves de novo targeting HPR to these 
heterochromatic regions followed by methylation of histone H3 lysine 9 and lysine 
27 to stabilize the heterochromatin and allow CHROMO domains to bind the 
methylated lysines. Subsequent events include the formation of sub-nuclear 
structures that contain protein machinery required for DNA rearrangement. 
This model makes a clear prediction that HPR should localize to 
heterochromatin DNA regions prior to histone H3K9 methylation. To test this, we 
can use SMT3 and UBC9 (generated by Qianyi Yang) conditional strains and 
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transfect them with GFP-HP1. Accumulation of HPR to heterochromatic regions in 
SMT3- and UBC9-depleted cells would suggest SUMO does not target HPR to 
heterochromatic regions of the developing MAC. A second method to test the same 
would be to make use of Lys mutants of GFP-HP1 that are unable to be SUMOylated 
expressed in wild-type Tetrahymena. If HPR is immunopurified using the V85K 
mutant, the exact site of Smt3p attachment on HP1 may be determined using the 
approach described above (see section on Identification of SUMOylation sites on 
protein substrates). Lys mutants of HPR would also help in identifying the site of 
Smt3p attachment. Western blot analysis would confirm the formation of SUMO-
modified species of HP1 (versus un-modified) if the target Lys is present in HP1. The 
slow-migrating band corresponding to the Smt3p-HPR would be absent in HP1 Lys 
mutants. Chromatin Immunoprecipitation (ChIP) assay will confirm whether SUMO-
HPR is physically associated with heterochromatic regions versus unmodified HPR1. 
SUMOylation of HPR may also modulate interactions with other proteins and could 
include other CHROMO domain-containing proteins such as Pdd1p and Pdd3p, both 
required for DNA elimination in Tetrahymena (96, 97). 
Another SUMO target of particular interest is the histone H2A variant, HTA3 
that was identified as a substrate of SUMO in Tetrahymena, yeast and fruit fly. In 
yeast, SUMOylation H2A.Z (HTA3 in Tetrahymena, TTHERM_00143660) serves as a 
specific chromatin mark for chromosome relocation to nuclear periphery for DSB 
repair (145, 165). Excision of IES elements in Tetrahymena, begins with induction of 
DSBs that eliminate mic-limited sequences followed by re-ligation of adjacent MAC-
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destined DNA. These events occur within DNA rearrangement foci in the developing 
macronucleus. Our model is that SUMO modification of HTA3 is required for its 
localization to DSBs in DNA rearrangement foci. Utilizing specific IES elements such 
as the M- or R-element is useful here as the excision of these IESs is well studied. 
GFP-tagged HTA3 along with the use of anti-Smt3p antibody can be used in 
immunofluorescence experiments to determine whether the two proteins co-
localize in the anlagen during MAC development. In addition to aiding DSB 
relocation, SUMOylation of HTA3 may be responsible for recruiting proteins 
involved in DSB repair by causing conformational changes that promote assembly of 
downstream repair factors. Homologous sequences are absent at DSB break sites 
and the cell switches to a type of Non-Homologous End Joining (NHEJ) repair 
mechanism as has been described in Paramecium (130). It is possible that the same 
process is in effect in Tetrahymena in the ligation of MAC-destined DNA following 
resection of IES elements. ChIP assays utilizing epitope-tagged versions of HTA3 can 
be used to identify interactions with other proteins and establish whether HTA3 is 
associated with eliminated heterochromatic on retained MAC-destined DNA regions. 
This will be especially helpful as Ku proteins and XRCC4 of the NHEJ pathways are 
known SUMO substrates and SUMOylation has well-defined roles in DNA repair 
(128). Conditional mutants of the SUMOylation pathway can be used to test for 
decreased SUMOylation status of HTA3. The SUMOylation-deficient strain (∆GG) can 
also be used to check reduction of histone SUMOylation. And RNAi-based approach 
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to reduce SUMOylation pathway protein levels can be effectively used to test 
whether cells accumulate DSBs in the anlagen as conjugation progresses. 
 
In vitro validation of Smt3p Conjugates found through Global MS Analysis 
The zinc-finger C2H2 protein and Glycine Cleavage System protein 
(TTHERM_00499390, here referred to as HPM1) are among the Smt3p proteins 
identified in our two-step purification procedure in Tetrahymena (Chapter 3) that 
were also identified in yeast or fruit fly. These proteins are of special interest 
because microarray expression data shows that transcript levels are upregulated for 
these proteins during conjugation, specifically during MAC development. This would 
suggest that these proteins are involved in the nuclear events of MAC development.  
We can validate these protein substrates as Smt3p conjugation targets using 
a bacterial SUMOylation assay. For this in vitro assay, we will generate E. coli 
expressed enzymes of the SUMOylation pathway from Tetrahymena thermophila 
(Smt3p, Aos1p/Uba2p, and Ubc9p) as well as epitope-tagged candidate Smt3p 
substrate. Single lysine mutants of Smt3p protein substrates will be used to confirm 
the exact site of Smt3p attachment. The detection of Smt3p conjugates in this system 
is facilitated by the lack of an absolute requirement for E3-type ligases in 
SUMOylation as well as by the absence of Smt3p proteases that deconjugate Smt3p 
from the substrate (reviewed in (2)). While bacterial SUMOylation systems may not 
completely recapitulate the specificity of SUMOylation reaction in vivo, they have 
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been repeatedly validated as a useful approach for confirming SUMOylation targets 
(48, 166). 
 
In vivo validation of Smt3p Conjugates found through Global MS Analysis 
To clearly demonstrate that a particular protein (e.g. HPM1, HTA3) is a target 
of Smt3p, an in vivo approach is most helpful in addition to the in vitro method 
described above. Most commonly this approach involves immunoprecipitation of 
the epitope-tagged form of the target protein. The use of denaturing lysis and 
affinity purification conditions helps to ensure that they type of interaction between 
the target protein and Smt3p is covalent in nature. This also helps in removal of 
non-covalently bound proteins as well as in the inhibition of SUMO proteases. 
Presence of a band in the immunoblot (probed with antibodies against the epitope 
tag) will confirm that the protein target is indeed a substrate of Smt3p. If antibodies 
for the protein substrates are available, then we can expect two bands in the 
immunoblots – one corresponding to the unmodified form of the protein substrate 
and another slower migrating band that will correspond to the SUMO-modified 
form. 
 
Non-ligatable Smt3p mutants serve as a good control for substrate validation 
The inactivated forms of UBLs require maturation before participation in the 
conjugation reaction. UBL proteases cleave the terminal residues of UBLs to reveal a 
diglycine (GG) motif that is necessary for isopeptide bond formation with the 
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acceptor Lys residue on target proteins. The evolutionary conservation of the GG 
motif across UBLs would suggest an absolute requirement for the GG motif in 
attachment to protein substrates. We have generated a series of C-terminal mutants 
of Smt3p all expressing the same His6-3FLAG double epitope tag described in 
Chapter 3. Immunoblotting analyses have shown that the deletions of any or all of 
the GG motif (GΔG and ΔGG) prevents formation of Smt3p adducts. These mutant 
strains where Smt3p cannot be conjugated to target proteins are useful in the 
affinity purification procedures used for the proteomics studies as proteins that are 
carried through the two purifications are highly abundant proteins and can be safely 
removed from the tagged Smt3p dataset.  
 
Undoubtedly more work will have to be undertaken to completely elucidate 
the protein substrates of Smt3p as well as the mechanisms by which Smt3p 
modification of these proteins regulates critical cellular pathways. For these 
purposes, Tetrahymena is a very useful model system as it exhibits nuclear 
dimorphism and allows for powerful forward and reverse genetics which will 
certainly provide insights into the essential nature of Smt3p. Studies such as ours 
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Figure 15. SMT3 KO heterokaryons undergo normal DNA elimination events during 
conjugation. Wild type (wt) and SMT3 KO heterokaryons (SMT3het) were mixed in 
three matings: wt × wt, wt × SMT3het, SMT3het × SMT3het. Cell lysates for PCR were 
prepared at mixing (t0). At 2 hours, >500 mated pairs were hand isolated into drops 
for each mating. After 24 hours (t24) when conjugation was complete the progeny 
were lysed and used as template in PCR reactions. The assay utilizes oligonucleotide 
primers that are able to amplify the unrearranged and rearranged forms of two IES 
elements (M and R). Comparison of PCR-amplified products on ethidium-bromide 
stained agarose gels, allowed visualization of the IES excision products. Only the 
longer 593 bp unrearranged form of the M element was found in the cells at t0, but 
the shorter 279 bp rearranged M element was the major product from progeny cells 
at t24 hours. This confirms that normal M element rearrangement occurred in 
progeny of SMT3 KO heterokaryons. There is only one R element product in the 
MAC but the amplified products are the same at t0 and t24 as expected in for normal 




Figure 16. Induction of the MTT1 promoter with cadmium allows SMT3 and UBA2 
conditional mutants to conjugate normally. SMT3 and UBA2 conditional strains 
grown and starved in the absence of cadmium are unable to form pairs when mixed 
together to induce conjugation. When CdCl2 (0.1 μg/mL) is added to these cells prior 
to mixing, these cells are able to form pairs and undergo normal conjugation. These 
mated cells were fixed and then stained with DAPI (to stain for nuclei). The time-
points shown here are at 2-2.5 hours (crescent micronuclei), 6 hours (pronuclei 
formation) and 8 hours (MAC Development). Wild-type cells induced with the same 








Table 6. List of oligos used in this study. 
Purpose Name Sequence (5’>3’) 
GFP constructs bzSUMO+1F CACCAATAAAATGACTGATTAAAACGCTAACGCT 
  bzSUMO+930R GATATCGAAAGAGCCACCAACTTGTTC 
  bzUBA2+1F CACCAAGGATATGAGTTTAGGAAGAATAAATC 
  bzUBA2+2262R GATATCCACTTTTAACTTTTTGTTGTCT 
   
Knockout cassette SMT3 5’flank F GTCACTCGAGGCAGTTTGTCTTTTATCCATTT 
  SMT3 5’flank R GCCGAGATCTCTTCAAATATTTATTGTTCGAC 
  SMT3 3’flank F ATCGGGATCCCTTCAAAATTTAGTTGATTGTGATAACA 
  SMT3 3’flank R ATTAGCGGCCGCATCTCAAATAAGTCTAAAT 
  UBA2 5’flank F ATCGCTCGAGAGTACTCGACGGATCTCATAAA 
  UBA2 5’flank R CGGCGGATCCACTCATATCCTTATCAATTAAA 
  UBA2 3’flank F ACGTGGATCCAAAGCTGTAGATTTTAGTTAAA 
  UBA2 3’flank R AACAGCGGCCGCTAGCTTATTAATTCTTCTA 
   
PCR to confirm knockout lines SMT3WT upstream F GATTGTTTGATGCTACATTCCTTC 
  SMT3WT upstream R TGCTAAAGACGGTTGGCTCT 
  UBA2WT upstream F TTTGCTTGTTGTTTGGTTTGTTT 
  UBA2WT upstream R CCAATGCCTCCTACACCAAT 
  MTTp 1940R TTTGCTAACCATAGCCAAAAT 
   
RT-PCR assay of conditional 
line 
SMT3WT 3’UTR F ACTGATTAAAACGCTAACGCT 






  BTU1 3’UTR R GTTGGTTTAGCTGACCGATTC 
  NEO3 3’ UTR F ACCGCTATCAGGACATA 
















Small ubiquitin-related modifier (SUMO), conjugated to lysine residues 
on target proteins, post-translational modification. 
5 
TTHERM_00641240 GPM1 Phosphoglycerate mutase. 4 
TTHERM_00585260 ATP2 ATP synthase beta chain, mitochondrial precursor, putative. 2 
TTHERM_00339620 RPL40 Ubiquitin-60S ribosomal protein L40. 5 
TTHERM_00346510  Ubiquitin family protein.  
TTHERM_00346560  Ubiquitin family protein. 3 
TTHERM_00085200  Ubiquitin family protein. 2 
TTHERM_01014750  dnaK protein belongs to the heat shock protein 70 family.  
TTHERM_00245410  




Citrate synthase; bifunctional 14-nm filament-forming protein; structural 
protein involved in oral morphogenesis and pronuclear behavior during 
conjugation; citrate synthase activity decreased by polymerization and 
dephosphorylation. 
2 
TTHERM_00196370 HSP60 HSP60; TCP-1/cpn60 chaperonin family protein.  
TTHERM_00399360  Hypothetical protein. 3 
TTHERM_00140850  Hypothetical protein. 5 
TTHERM_00185230  Triosephosphate isomerase. 2 
TTHERM_00028780  Hypothetical protein.  







Putative 70-kDa heat-shock protein (hsp70); two forms of hsp70 
associate with tubulin, mitochondrial hsp70 associates with 14-nm 
filament protein (14FP), hsp70 proteins have evolutionarily conserved 
roles in folding nascent polypeptides. 
 
TTHERM_00125640 SSA3 HSP70a paralog; dnaK protein.  
TTHERM_00558440 SSA5 HSP70a paralog; dnaK protein.  
TTHERM_00143660 HTA3 
Histone H2A (variant H2A.Z); essential protein; regulated by acetylation, 
which modulates charge patch on its N-terminal tail; comprises about 




Ribosomal Protein of the Large subunit #20;  Homolog of Yeast RPL20, 
Human RPL18A; Ribosomal L18ae protein family protein. 
2 
TTHERM_01528510  Hypothetical protein. 2 
TTHERM_00487110 PRE10 20S proteasome core alpha subunit 7.  
TTHERM_00375130  Carboxyvinyl-carboxyphosphonate phosphorylmutase-related.  
TTHERM_00895810  Hypothetical protein. 3 
TTHERM_01029940  Hypothetical protein. 4 
TTHERM_00075670 RPL43 
Ribosomal Protein of the Large subunit #43; Homolog of Yeast RPL43, 
Human RPL37A. 
 
TTHERM_01014740  Hypothetical protein.  
TTHERM_01113100  
40S ribosomal protein RACK1 (Receptor for Activated C Kinase 1); 
homolog of yeast ASC1. 
2 
TTHERM_00068170 TCB2 
Tetrahymena Calcium-Binding protein; 25 kD Ca(2+)-binding protein 
containing four EF-hand loops; localized to cell cortex except in and 
around basal bodies, and around both the migratory and the stationary 
gametic pronuclei during pronuclear exchange. 
 






TTHERM_00926980  Acetyl-CoA acyltransferases family protein.  
TTHERM_00068120  Hypothetical protein, acyltransferase domain.  
TTHERM_00028740 RPL12 
Ribosomal Protein of the Large subunit #12; Homolog of Yeast RPL12, 
Human RPL12, Bacterial RPL11; Ribosomal protein L11; RNA binding 
domain containing protein. 
 
TTHERM_00467660 RPS24 
Ribosomal Protein of the Small subunit 24; Homolog of yeast RPS24, 
human RPS24. 
 
TTHERM_01100380  Hypothetical protein.  
TTHERM_00068140  Succinyl-CoA synthetase, alpha subunit family protein.  
TTHERM_00522720 UBC9 
SUMO-conjugating enzyme involved in the Smt3p conjugation pathway; a 
member of the ubiquitin-conjugating enzyme E2 family. 
2 
TTHERM_00420030  Phosphoenolpyruvate carboxykinase.  
TTHERM_00216150  
Hypothetical protein, Telomere stability and silencing; telomere stability 
C-terminal domain; Sde2 domain. 
 
TTHERM_00333210 RPL4 




Glycolytic enzyme phosphoglucose isomerase, catalyzes the 
interconversion of glucose-6-phosphate and fructose-6-phosphate. 
 
TTHERM_00571860 ATP1 ATP synthase F1; alpha subunit family protein.  
TTHERM_00535530  Hypothetical protein. 2 
TTHERM_00522810  Hypothetical protein. 2 
TTHERM_00047080  Succinate dehydrogenase; flavoprotein subunit containing protein. 2 
TTHERM_00250870  Dual specificity phosphatase; catalytic domain containing protein.  
TTHERM_00011390  Hypothetical protein. 4 







Ribosomal protein of the large subunit; Homolog of yeast RPL15 
(/RPL15e). 
 
TTHERM_00053800  FAD binding domain containing protein.  
TTHERM_00128280 DFB1 
Deep fiber bundle protein 1; localizes to the deep fiber bundle of the oral 
apparatus, forms filamentous structures, associates with basal bodies 
and longitudinal microtubules. 
 
TTHERM_00225860  
C2 domain. This repeat is found in a wide variety of proteins and 
generally consists of the motif XYPPX where X can be any amino acid. 
2 
TTHERM_01109770 RPS11 
Ribosomal Protein of the Small subunit 11; Homolog of yeast RPS11, 
human RPS, bacterial RPS17. 
 
TTHERM_00152140  
Brix domain containing protein. Proteins from the Imp4/Brix 
superfamily appear to be involved in ribosomal RNA processing, which 
essential for the functioning of all cells. 
 
TTHERM_00780640  Hypothetical protein.  
TTHERM_00667010  
HSA domain (domain is predicted to bind DNA and is often found 
associated with helicases). 
 
TTHERM_01146030 CAT1 
Catalase; peroxisomal enzyme involved in the metabolism of hydrogen 
peroxide; enzyme activity induced by linolenic acid. 
2 
TTHERM_00047230  Myb/SANT-like DNA-binding domain.  
TTHERM_00047580  Uroporphyrinogen decarboxylase family protein.  
TTHERM_00393040  Hypothetical protein.  
TTHERM_00859260  
EF-1 guanine nucleotide exchange domain containing protein. Eukaryotic 




Eukaryotic translation Elongation Factor; catalyzes ribosomal 
translocation during protein synthesis; mRNA is expressed during 








TTHERM_00736480 RPL5 Ribosomal L18p/L5e family protein  
TTHERM_00499390  
Glycine cleavage system T protein. Sequence similarity to the HisK 
protein kinase family. The system is a series of enzymes that are 
triggered in response to high concentrations of the amino acid glycine. 
 
TTHERM_01094890  Hypothetical protein.  
TTHERM_00245120  Hypothetical protein. 2 
TTHERM_00852720  Zinc finger, C2H2 type. 2 
TTHERM_01043090 RPS27 




CAP-Gly domain containing protein. CAP domain containing proteins are 
involved in organizing microtubules. The CAP-Gly domain is a conserved 
glycine-rich variant of the CAP domain. CAP-Gly domain bind to C-
terminal sequence motifs present in α-tubulin and in other microtubule-
associated proteins.  
2 
TTHERM_01299660  
SCP-2 sterol transfer family protein. Sterol carrier proteins (also known 
as nonspecific lipid transfer proteins) is a family of proteins that transfer 
steroids and probably also phospholipids and gangliosides between 
cellular membranes. 
 
TTHERM_00971960  Hypothetical protein. 2 
TTHERM_00044990  Fumarylacetoacetase family protein; FAA_hydrolase domain.  
TTHERM_00486310  Hypothetical protein.  
TTHERM_00066950  Pyridine nucleotide-disulphide oxidoreductase family protein.  
TTHERM_01097920  Hypothetical protein. 2 
TTHERM_01001220  Hypothetical protein.  
TTHERM_01129660 RPL36 
Ribosomal Protein of the Large subunit 36; Homolog of Yeast RPL36, 







TTHERM_00487090  Fructose-bisphosphate aldolase class-I family protein.  
TTHERM_00522370  Cation channel family protein; ion transport protein.  2 
TTHERM_00149300 RPS4 
Ribosomal Protein of the Small subunit 4; Homolog of yeast RPS4, human 
RPS4. 
 
TTHERM_00773350  Hypothetical protein.  
TTHERM_00762890 RPS17 




Tetrin A; novel, insoluble cytoskeletal protein with molecular mass of 
around 85 kD; unique to cilia. 
 
TTHERM_01020870  Zinc finger, C2H2 type family protein.  
TTHERM_00157949  Hypothetical protein.  
TTHERM_00357080 SOD1 Superoxide dismutase.  
TTHERM_00011400  Myb-like DNA-binding domain containing protein. 2 
TTHERM_00227270 RPL22 
Ribosomal Protein of the Large subunit #22; Homolog of Yeast RPL22, 
Human RPL22. 
 
TTHERM_01053030  CCT motif family protein.  
TTHERM_00402120  Glutathione S-transferase, N-terminal domain containing protein.  
TTHERM_00415630  Hypothetical protein.  
TTHERM_00299840  Methylmalonate-semialdehyde dehydrogenase family protein.  
TTHERM_00151850  
Ser/Thr protein phosphatase family protein, Calcineurin-like 
phosphoesterase superfamily domain. 
 
TTHERM_00444800  Hypothetical protein.  
TTHERM_00134940 RPL25 
Ribosomal Protein of the Large subunit #25; Homolog of Yeast RPL25, 
Human RPL23A, Bacteria RPL23; Ribosomal protein L23 containing 
protein. 
 






TTHERM_00499420 TGP1 G-quartet DNA-binding protein TGP1.  
TTHERM_00568050  HMG (high mobility group) box family protein.  
TTHERM_00361490  Hypothetical protein.  
TTHERM_00145440  Alpha/beta hydrolase family protein.  
TTHERM_01026240  Phytanoyl-CoA dioxygenase (PhyH).  
TTHERM_00518610 DIM1 Mitosis protein DIM1.  
TTHERM_00535700  RING-variant domain, FHA domain protein, putative.  
TTHERM_00824010  Ubiquitin-conjugating enzyme, putative.  
TTHERM_00046870  




Myosin heavy chain; member of proposed myosin Class XX, distinct from 
previously defined myosin classes; contains predicted coiled-coil, myosin 
tail homology (MyTH4), and FERM domains. 
 
TTHERM_00400750  




Tetrahymena homolog of the liver F-Antigen; Homolog of vertebrate liver 
F-antigen; constituent of the intracellular membrane network; associated 
with membranes of the Golgi apparatus and transport vesicles. 
2 
TTHERM_00429890  Nucleoplasmin protein.  
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